<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">RSC Adv</journal-id><journal-id journal-id-type="iso-abbrev">RSC Adv</journal-id><journal-id journal-id-type="publisher-id">RA</journal-id><journal-id journal-id-type="coden">RSCACL</journal-id><journal-title-group><journal-title>RSC Advances</journal-title></journal-title-group><issn pub-type="epub">2046-2069</issn><publisher><publisher-name>The Royal Society of Chemistry</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9169493</article-id><article-id pub-id-type="publisher-id">d2ra02094g</article-id><article-id pub-id-type="doi">10.1039/d2ra02094g</article-id><article-categories><subj-group subj-group-type="heading"><subject>Chemistry</subject></subj-group></article-categories><title-group><article-title>Allopeptimicins: unique antibacterial metabolites generated by hybrid PKS-NRPS, with original self-defense mechanism in <italic toggle="yes">Actinoallomurus</italic><xref rid="fn1" ref-type="fn">&#x02020;</xref></article-title><fn-group><fn id="fn1"><label>&#x02020;</label><p>Electronic supplementary information (ESI) available. See <uri xlink:href="https://doi.org/10.1039/d2ra02094g">https://doi.org/10.1039/d2ra02094g</uri></p></fn></fn-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8669-5875</contrib-id><name><surname>Iorio</surname><given-names>Marianna</given-names></name><xref rid="affa" ref-type="aff"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1224-1130</contrib-id><name><surname>Gentile</surname><given-names>Andrea</given-names></name><xref rid="affa" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Brunati</surname><given-names>Cristina</given-names></name><xref rid="affa" ref-type="aff"/><xref rid="affb" ref-type="aff"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7004-7582</contrib-id><name><surname>Tocchetti</surname><given-names>Arianna</given-names></name><xref rid="affa" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Landini</surname><given-names>Paolo</given-names></name><xref rid="affc" ref-type="aff"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5489-5995</contrib-id><name><surname>Maffioli</surname><given-names>Sonia Ilaria</given-names></name><xref rid="affa" ref-type="aff"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2121-8979</contrib-id><name><surname>Donadio</surname><given-names>Stefano</given-names></name><xref rid="affa" ref-type="aff"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4297-6936</contrib-id><name><surname>Sosio</surname><given-names>Margherita</given-names></name><xref rid="affa" ref-type="aff"/><xref rid="affb" ref-type="aff"/></contrib><aff id="affa">
<institution>NAICONS Srl</institution>
<city>Milan</city>
<country>Italy</country>
<email>miorio@naicons.com</email>
</aff><aff id="affb">
<institution>Ktedogen Srl</institution>
<city>Milan</city>
<country>Italy</country>
</aff><aff id="affc">
<institution>Bioscience Dept., University of Milan</institution>
<country>Italy</country>
</aff></contrib-group><pub-date publication-format="electronic" date-type="pub" iso-8601-date="2022-06-06"><day>6</day><month>6</month><year>2022</year></pub-date><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2022-06-01"><day>1</day><month>6</month><year>2022</year></pub-date><pub-date pub-type="pmc-release"><day>6</day><month>6</month><year>2022</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>12</volume><issue>26</issue><fpage>16640</fpage><lpage>16655</lpage><history><date date-type="received" iso-8601-date="2022-03-31"><day>31</day><month>3</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-05-25"><day>25</day><month>5</month><year>2022</year></date></history><permissions><copyright-statement>This journal is &#x000a9; The Royal Society of Chemistry</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>The Royal Society of Chemistry</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense" start_date="2022-06-06">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref></license></permissions><abstract><p>In the search for structurally novel metabolites with antibacterial activity, innovative approaches must be implemented to increase the probability of discovering novel chemistry from microbial sources. Here we report on the application of metabolomic tools to the genus <italic toggle="yes">Actinoallomurus</italic>, a poorly explored member of the Actinobacteria. From examining extracts derived from 88 isolates belonging to this genus, we identified a family of cyclodepsipeptides acylated with a C<sub>20</sub> polyketide chain, which we named allopeptimicins. These molecules possess unusual structural features, including several double bonds in the amino-polyketide chain and four non-proteinogenic amino acids in the octapeptide. Remarkably, allopeptimicins are produced as a complex of active and inactive congeners, the latter carrying a sulfate group on the polyketide amine. This modification is also a mechanism of self-protection in the producer strain. The structural uniqueness of allopeptimicins is reflected in a biosynthetic gene cluster showing a mosaic structure, with dedicated gene cassettes devoted to formation of specialized precursors and modular assembly lines related to those from different pathways.</p></abstract><abstract abstract-type="toc"><p>Untargeted metabolomic analysis of <italic toggle="yes">Actinoallomurus</italic> spp. unveiled an unprecedented acylated cyclodepsipeptide with unusual features and potent antibacterial activity.<graphic xlink:href="d2ra02094g-ga.jpg" id="ga" position="float"/></p></abstract><funding-group><award-group><funding-source>
<institution-wrap><institution>Horizon 2020 Framework Programme</institution><institution-id institution-id-type="doi">10.13039/100010661</institution-id></institution-wrap>
</funding-source><award-id>664588</award-id></award-group><award-group><funding-source>
<institution-wrap><institution>Ministero dell'Universit&#x000e0; e della Ricerca</institution><institution-id institution-id-type="doi">10.13039/501100021856</institution-id></institution-wrap>
</funding-source><award-id>DM60066</award-id></award-group></funding-group><counts><page-count count="16"/></counts><custom-meta-group><custom-meta><meta-name>pubstatus</meta-name><meta-value>Paginated Article</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>Introduction</title><p>The spread of antibiotic resistance is a serious threat to public health that is forecast to reach dramatic levels by 2050, exacerbated by the scarcity of new antibacterial drugs in the development pipeline.<sup><xref rid="cit1" ref-type="bibr">1</xref></sup> Most of the antibiotics in clinical use today are microbial metabolites or derivatives thereof,<sup><xref rid="cit2" ref-type="bibr">2</xref></sup> while alternative approaches to antibiotic discovery have so far failed to be as successful as microbial product screening.<sup><xref rid="cit2" ref-type="bibr">2</xref></sup> However, through several decades of large screening efforts, thousands of metabolites with antibacterial activity have been reported in the literature, rendering the discovery of new scaffolds by bioactivity-based screening a labor-intensive endeavor.</p><p>It is generally believed that the known metabolites represent the tip of the iceberg of molecules produced by microorganisms and that alternative approaches can reduce the biases imposed by bioassay-based screens.<sup><xref rid="cit1" ref-type="bibr">1,3,4</xref></sup> An attractive approach is represented by employing mass-spectrometry (MS)-based metabolomic tools to navigate the chemical complexity observed in microbial fermentation extracts. Recent advancements in this area are represented by molecular networking tools<sup><xref rid="cit5" ref-type="bibr">5</xref></sup> and by machine learning that, combined with publicly accessible databases, have greatly expedited metabolite annotation and prioritization for further investigations.<sup><xref rid="cit6" ref-type="bibr">6,7</xref></sup> Particularly promising is the combination of metabolomic tools to poorly explored bacterial taxa. In recent work on bacterial strains belonging to the actinobacterial genus <italic toggle="yes">Planomonospora</italic>, we uncovered novel chemistry, which led to a family of unexpected biosynthetic gene clusters (BGCs),<sup><xref rid="cit8" ref-type="bibr">8,9</xref></sup> which in turn helped uncover further novel chemistry.<sup><xref rid="cit10" ref-type="bibr">10</xref></sup></p><p>We previously reported that strains belonging to another actinobacterial genus, <italic toggle="yes">Actinoallomurus</italic>, produce at high frequency molecules with antibacterial activity,<sup><xref rid="cit11" ref-type="bibr">11</xref></sup> with several new variants of known scaffolds identified through bioactivity-based screening.<sup><xref rid="cit12" ref-type="bibr">12&#x02013;16</xref></sup> Here we report that metabolomic analysis of <italic toggle="yes">Actinoallomurus</italic> spp. unveiled an unprecedented acylated cyclodepsipeptide with unusual features and potent antibacterial activity.</p></sec><sec><title>Results and discussion</title><sec><title>Discovery of allopeptimicins</title><p>Microbial fermentation extracts derived from 88 <italic toggle="yes">Actinoallomurus</italic> strains from the NAICONS collection were analyzed by low resolution LC-MS/MS followed by molecular networking (Fig. S1<xref rid="fn1" ref-type="fn">&#x02020;</xref>), which evidenced previously reported metabolites such as the polyether &#x003b1;-823,<sup><xref rid="cit11" ref-type="bibr">11</xref></sup> the paramagnetoquinones,<sup><xref rid="cit12" ref-type="bibr">12</xref></sup> the allocyclinones,<sup><xref rid="cit13" ref-type="bibr">13</xref></sup> and the isoflavonoids genistein and daidzein.<sup><xref rid="cit16" ref-type="bibr">16</xref></sup></p><p>Among all the observed clusters, one molecular family attracted our attention: it was associated with an extract generated from strain ID145808 only and was absent in extracts from the remaining 87 strains. This molecular family consisted of a group of metabolites characterized by a parent mass of around 1200 amu (Fig. S1<xref rid="fn1" ref-type="fn">&#x02020;</xref>), whose fragmentation spectra showed no matches to the 11&#x02009;600 MassIVe datasets present in the GNPS repository (<uri xlink:href="https://gnps.ucsd.edu/">https://gnps.ucsd.edu/</uri>) and to our private spectral library of metabolic profiles from about 14&#x02009;000 extracts. Interestingly, the microbial extract coming from strain ID145808 possessed activity against <italic toggle="yes">Staphylococcus aureus</italic>.</p><p>HPLC fractionation of the ID145808 extract followed by bioassay of the resulting fractions enabled signal deconvolution: a group of related molecules with <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> of 1205, 1207, 1219 and 1221 [M + H]<sup>+</sup> and elution times of 6.76, 6.79, 6.90 and 7.07 min, respectively (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). Thus, the four related molecules could be accounted for by mass differences of 2 and 14 amu. Inspection of the LC-MS profile of the entire extract revealed a second group of four related molecules with mass distances of 2 and 14 amu. This second group of molecules, eluting between 7.53 and 8.05 min, was present in HPLC fractions devoid of antibacterial activity (<xref rid="fig1" ref-type="fig">Fig. 1</xref>) and showed <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> of 1285, 1287, 1299 and 1301 [M + H]<sup>+</sup>. Thus, molecules from one group differed by 80 amu from molecules of the other group. All molecules from both groups shared the same UV spectrum with four maxima: the first at 239 nm (<italic toggle="yes">&#x003b5;</italic>/dm<sup>3</sup> mol<sup>&#x02212;1</sup> cm<sup>&#x02212;1</sup> 23&#x02009;700) and a distinctive tricuspid absorption at 260 (25&#x02009;100), 270 (31&#x02009;000) and 280 nm (24&#x02009;200), suggestive of three conjugated double bonds. High resolution mass spectrometry (HR-MS) analysis resolved the distances among the congeners as two hydrogens, a methylene group and a sulphate moiety, as indicated by the molecular formulas reported in <xref rid="tab1" ref-type="table">Table 1</xref>. The active and inactive congeners were named allopeptimicin A1 through A4 and B1 through B4, respectively. The most abundant congener in each group were A3 and B4.</p><fig position="float" id="fig1"><label>Fig. 1</label><caption><title>(A) HPLC profile of the extracted fermentation broth from a culture of <italic toggle="yes">Actinoallomurus</italic> ID145808. The green and red boxes denote the regions of the chromatogram containing fractions with and devoid of antibacterial activity, respectively. (B) MS of the highlighted regions in (A). (C and D) UV-Vis spectra of the fractions at 6.89 and 7.88 minutes, respectively.</title></caption><graphic xlink:href="d2ra02094g-f1" position="float"/></fig><table-wrap position="float" id="tab1"><caption><title>Properties of allopeptimicin congeners and fragments thereof, and number of added acetyls</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Congener</th><th rowspan="1" colspan="1">Molecular formula</th><th rowspan="1" colspan="1">
<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> found [M + H]<sup>+</sup></th><th rowspan="1" colspan="1">
<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> calculated [M + H]<sup>+</sup></th><th rowspan="1" colspan="1">Number of added acetyls</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Allopeptimicin A1</td><td rowspan="1" colspan="1">C<sub>62</sub>H<sub>96</sub>N<sub>10</sub>O<sub>14</sub></td><td align="char" char="." rowspan="1" colspan="1">1205.7182</td><td align="char" char="." rowspan="1" colspan="1">1205.7180</td><td rowspan="1" colspan="1">3</td></tr><tr><td rowspan="1" colspan="1">Allopeptimicin A2</td><td rowspan="1" colspan="1">C<sub>62</sub>H<sub>98</sub>N<sub>10</sub>O<sub>14</sub></td><td align="char" char="." rowspan="1" colspan="1">1207.7348</td><td align="char" char="." rowspan="1" colspan="1">1207.7337</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">Allopeptimicin A3</td><td rowspan="1" colspan="1">C<sub>63</sub>H<sub>98</sub>N<sub>10</sub>O<sub>14</sub></td><td align="char" char="." rowspan="1" colspan="1">1219.7341</td><td align="char" char="." rowspan="1" colspan="1">1219.7337</td><td rowspan="1" colspan="1">3</td></tr><tr><td rowspan="1" colspan="1">Allopeptimicin A4</td><td rowspan="1" colspan="1">C<sub>63</sub>H<sub>100</sub>N<sub>10</sub>O<sub>14</sub></td><td align="char" char="." rowspan="1" colspan="1">1221.7493</td><td align="char" char="." rowspan="1" colspan="1">1221.7493</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">Allopeptimicin B1</td><td rowspan="1" colspan="1">C<sub>62</sub>H<sub>96</sub>N<sub>10</sub>O<sub>17</sub>S</td><td align="char" char="." rowspan="1" colspan="1">1285.6755</td><td align="char" char="." rowspan="1" colspan="1">1285.6748</td><td rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">Allopeptimicin B2</td><td rowspan="1" colspan="1">C<sub>62</sub>H<sub>98</sub>N<sub>10</sub>O<sub>17</sub>S</td><td align="char" char="." rowspan="1" colspan="1">1287.6911</td><td align="char" char="." rowspan="1" colspan="1">1287.6905</td><td rowspan="1" colspan="1">3</td></tr><tr><td rowspan="1" colspan="1">Allopeptimicin B3</td><td rowspan="1" colspan="1">C<sub>63</sub>H<sub>98</sub>N<sub>10</sub>O<sub>17</sub>S</td><td align="char" char="." rowspan="1" colspan="1">1299.6909</td><td align="char" char="." rowspan="1" colspan="1">1299.6905</td><td rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">Allopeptimicin B4</td><td rowspan="1" colspan="1">C<sub>63</sub>H<sub>100</sub>N<sub>10</sub>O<sub>17</sub>S</td><td align="char" char="." rowspan="1" colspan="1">1301.7063</td><td align="char" char="." rowspan="1" colspan="1">1301.7061</td><td rowspan="1" colspan="1">3</td></tr><tr><td rowspan="1" colspan="1">Hydrolytic fragment</td><td rowspan="1" colspan="1">C<sub>17</sub>H<sub>31</sub>N<sub>2</sub>O<sub>8</sub></td><td align="char" char="." rowspan="1" colspan="1">391.2046</td><td align="char" char="." rowspan="1" colspan="1">391.2075</td><td rowspan="1" colspan="1">Not done</td></tr></tbody></table></table-wrap></sec><sec><title>Structure elucidation</title><p>The molecular formulas together with the peculiar UV absorption of allopeptimicins suggested a peptide&#x02013;polyketide skeleton: the peptide portion would be consistent with the presence of several nitrogen and oxygen atoms, while the large number of carbons and the conjugated double bonds predicted from the UV spectrum pointed to a long hydrocarbon portion. Under alkaline conditions all allopeptimicin congeners underwent hydrolysis with the elimination of 390 amu after the addition of two water molecules, suggesting the presence of two hydrolysable bonds, likely esters, in a cyclic structure (Fig. S2A and B<xref rid="fn1" ref-type="fn">&#x02020;</xref>). Amidation with methylamine led to the formation of one methylamide in each congener (Fig. S2C and D<xref rid="fn1" ref-type="fn">&#x02020;</xref>), revealing the presence of one free carboxylic acid. Acetylation reactions, carried out in order to establish the number of free amines or hydroxyls, showed differences among congeners, with the incorporation of two, three or four acetyls, with a clear pattern (<xref rid="tab1" ref-type="table">Table 1</xref>): congener pairs differing for one methylene group (A1 and A3, B1 and B3, A2 and A4, and B2 and B4) incorporated an identical number of acetyls while, in congeners differing by 2 amu, the smaller congener always incorporated one lesser acetyl group, indicating that the unsaturation in A1, B1, A3 and B3 involves an amine or a hydroxyl. Members of the B group incorporated one lesser acetyl than the corresponding members of the A group, suggesting that the sulphate moiety is present on an amine. [A sulphate ester is expected to hydrolyze under alkaline conditions.]</p><p>These properties of allopeptimicins guided interpretation of extensive 1D- and 2D-NMR experiments and HR-tandem MS analyses. A set of NMR experiments (<xref rid="tab2" ref-type="table">Table 2</xref> and Fig. S3&#x02013;S8<xref rid="fn1" ref-type="fn">&#x02020;</xref>) in CD<sub>3</sub>CN/D<sub>2</sub>O 8&#x02009;:&#x02009;2 was performed on a sample containing the A congeners in the following proportion: A1&#x02009;:&#x02009;A2&#x02009;:&#x02009;A3&#x02009;:&#x02009;A4 15&#x02009;:&#x02009;10&#x02009;:&#x02009;45&#x02009;:&#x02009;30.</p><table-wrap position="float" id="tab2"><caption><title>
<sup>1</sup>H and <sup>13</sup>C NMR spectral data of allopeptimicin A3 and B3 measured at 300 MHz in CD<sub>3</sub>CN&#x02009;:&#x02009;D<sub>2</sub>O&#x02009;:&#x02009;H<sub>2</sub>O 4&#x02009;:&#x02009;1&#x02009;:&#x02009;0.2</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1">Unit</th><th rowspan="2" colspan="1">Position</th><th colspan="3" rowspan="1">Allopeptimicin A3</th><th colspan="2" rowspan="1">Allopeptimicin B3</th></tr><tr><th rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
<sub>H</sub> (multiplicity, <italic toggle="yes">J</italic> coupling when visible (Hz))</th><th rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
<sub>C</sub>
</th><th rowspan="1" colspan="1">NOE correlations</th><th rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
<sub>H</sub> (multiplicity, <italic toggle="yes">J</italic> coupling when visible (Hz))</th><th rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
<sub>C</sub>
</th></tr></thead><tbody><tr><td rowspan="8" colspan="1">Ile_1</td><td rowspan="1" colspan="1">NH</td><td rowspan="1" colspan="1">7.01</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.76 (methyl in C2&#x02013;acyl chain)</td><td rowspan="1" colspan="1">6.97</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">C<private-char name="DOUBLE BOND, LENGTH AS M-DASH" description="double bond, length as m-dash"><!-- PBM data was replaced with SVG by xgml2pxml:
<glyph-data id="z.dbd" format="PBM" resolution="300" x-size="8" y-size="10" xml:space="preserve">
00000000
00000000
00000000
00000000
11111111
00000000
11111111
00000000
00000000
00000000
</glyph-data>
-->
<glyph-data id="z.dbd" format="SVG" resolution="300" x-size="8" y-size="10" xml:space="preserve">
<![CDATA[
<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>
]]>
</glyph-data></private-char>O</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">172.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">172.3</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b1;</italic>
</td><td rowspan="1" colspan="1">4.34 (t, 7.0)</td><td rowspan="1" colspan="1">57.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4.34 (t, 7.0)</td><td rowspan="1" colspan="1">57.4</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
</td><td rowspan="1" colspan="1">1.86</td><td rowspan="1" colspan="1">36.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.86</td><td rowspan="1" colspan="1">36.7</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
<sub>a</sub>
</td><td rowspan="1" colspan="1">1.32</td><td rowspan="2" colspan="1">25.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.33</td><td rowspan="2" colspan="1">25.9</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
<sub>b</sub>
</td><td rowspan="1" colspan="1">1.10</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.08</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
</td><td rowspan="1" colspan="1">0.85 (d, 7.0)</td><td rowspan="1" colspan="1">11.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.86 (d, 7.0)</td><td rowspan="1" colspan="1">11.0</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b5;</italic>
</td><td rowspan="1" colspan="1">0.84</td><td rowspan="1" colspan="1">14.1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.84</td><td rowspan="1" colspan="1">14.1</td></tr><tr><td rowspan="6" colspan="1">Val_2</td><td rowspan="1" colspan="1">NH</td><td rowspan="1" colspan="1">7.58</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4.34 (C2&#x02013;Ile_1)</td><td rowspan="1" colspan="1">7.56</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">C<private-char name="DOUBLE BOND, LENGTH AS M-DASH" description="double bond, length as m-dash"><glyph-ref glyph-data="z.dbd"/></private-char>O</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">171.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">171.4</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b1;</italic>
</td><td rowspan="1" colspan="1">4.16</td><td rowspan="1" colspan="1">58.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4.16</td><td rowspan="1" colspan="1">58.9</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
</td><td rowspan="1" colspan="1">2.00</td><td rowspan="1" colspan="1">30.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.00</td><td rowspan="1" colspan="1">30.6</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
</td><td rowspan="1" colspan="1">0.86 (d, 7.0)</td><td rowspan="1" colspan="1">17.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.85 (d, 7.0)</td><td rowspan="1" colspan="1">18.8</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
</td><td rowspan="1" colspan="1">0.87 (d, 7.0)</td><td rowspan="1" colspan="1">18.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.90 (d, 7.0)</td><td rowspan="1" colspan="1">18.6</td></tr><tr><td rowspan="5" colspan="1">Thr_3</td><td rowspan="1" colspan="1">NH</td><td rowspan="1" colspan="1">7.76</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4.16 (C2&#x02013;Val_2)</td><td rowspan="1" colspan="1">7.80</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">C<private-char name="DOUBLE BOND, LENGTH AS M-DASH" description="double bond, length as m-dash"><glyph-ref glyph-data="z.dbd"/></private-char>O</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">169.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">169.7</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b1;</italic>
</td><td rowspan="1" colspan="1">4.81</td><td rowspan="1" colspan="1">57.1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4.86</td><td rowspan="1" colspan="1">56.7</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
</td><td rowspan="1" colspan="1">5.33</td><td rowspan="1" colspan="1">70.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5.30</td><td rowspan="1" colspan="1">70.8</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
</td><td rowspan="1" colspan="1">1.22</td><td rowspan="1" colspan="1">17.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.20</td><td rowspan="1" colspan="1">17.3</td></tr><tr><td rowspan="8" colspan="1">Piz_4</td><td rowspan="1" colspan="1">C<private-char name="DOUBLE BOND, LENGTH AS M-DASH" description="double bond, length as m-dash"><glyph-ref glyph-data="z.dbd"/></private-char>O</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">172.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">172.4</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b1;</italic>
</td><td rowspan="1" colspan="1">5.46</td><td rowspan="1" colspan="1">50.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5.46</td><td rowspan="1" colspan="1">50.7</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
<sub>a</sub>
</td><td rowspan="1" colspan="1">2.09</td><td rowspan="2" colspan="1">25.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.10</td><td rowspan="2" colspan="1">25.4</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
<sub>b</sub>
</td><td rowspan="1" colspan="1">1.84</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.78</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
<sub>a</sub>
</td><td rowspan="1" colspan="1">1.53</td><td rowspan="2" colspan="1">20.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.53</td><td rowspan="2" colspan="1">20.7</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
<sub>b</sub>
</td><td rowspan="1" colspan="1">1.49</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.46</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
<sub>a</sub>
</td><td rowspan="1" colspan="1">2.99</td><td rowspan="2" colspan="1">46.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3.00</td><td rowspan="2" colspan="1">46.1</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
<sub>b</sub>
</td><td rowspan="1" colspan="1">2.69</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.73</td></tr><tr><td rowspan="7" colspan="1">Piz_5</td><td rowspan="1" colspan="1">C<private-char name="DOUBLE BOND, LENGTH AS M-DASH" description="double bond, length as m-dash"><glyph-ref glyph-data="z.dbd"/></private-char>O</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">170.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">170.8</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b1;</italic>
</td><td rowspan="1" colspan="1">5.15</td><td rowspan="1" colspan="1">50.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5.17</td><td rowspan="1" colspan="1">50.7</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
<sub>a</sub>
</td><td rowspan="1" colspan="1">2.31</td><td rowspan="2" colspan="1">18.1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.31</td><td rowspan="2" colspan="1">18.1</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
<sub>b</sub>
</td><td rowspan="1" colspan="1">1.99</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.97</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
<sub>a</sub>
</td><td rowspan="1" colspan="1">2.25</td><td rowspan="2" colspan="1">20.1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.22</td><td rowspan="2" colspan="1">20.2</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
<sub>b</sub>
</td><td rowspan="1" colspan="1">1.98</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.07</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
</td><td rowspan="1" colspan="1">6.96</td><td rowspan="1" colspan="1">145.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">6.98</td><td rowspan="1" colspan="1">145.5</td></tr><tr><td rowspan="7" colspan="1">Hmg_6</td><td rowspan="1" colspan="1">C<private-char name="DOUBLE BOND, LENGTH AS M-DASH" description="double bond, length as m-dash"><glyph-ref glyph-data="z.dbd"/></private-char>O</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">169.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">169.7</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b1;</italic>
</td><td rowspan="1" colspan="1">4.99</td><td rowspan="1" colspan="1">73.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5.09</td><td rowspan="1" colspan="1">72.9</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
<sub>a</sub>
</td><td rowspan="1" colspan="1">2.01</td><td rowspan="2" colspan="1">34.1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.00</td><td rowspan="2" colspan="1">34.2</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
<sub>b</sub>
</td><td rowspan="1" colspan="1">1.99</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.99</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
</td><td rowspan="1" colspan="1">2.59</td><td rowspan="1" colspan="1">35.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.60</td><td rowspan="1" colspan="1">35.2</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">178.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">178.0</td></tr><tr><td rowspan="1" colspan="1">&#x003b3;-Me</td><td rowspan="1" colspan="1">1.15 (d, 6.8)</td><td rowspan="1" colspan="1">16.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.15 (d, 6.8)</td><td rowspan="1" colspan="1">16.8</td></tr><tr><td rowspan="5" colspan="1">Thr_7</td><td rowspan="1" colspan="1">NH</td><td rowspan="1" colspan="1">7.73</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4.99 (C2&#x02013;Hmg_6)</td><td rowspan="1" colspan="1">7.91</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">C<private-char name="DOUBLE BOND, LENGTH AS M-DASH" description="double bond, length as m-dash"><glyph-ref glyph-data="z.dbd"/></private-char>O</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">171.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">171.6</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b1;</italic>
</td><td rowspan="1" colspan="1">4.70</td><td rowspan="1" colspan="1">54.5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4.72</td><td rowspan="1" colspan="1">54.5</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
</td><td rowspan="1" colspan="1">3.89</td><td rowspan="1" colspan="1">67.5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3.88</td><td rowspan="1" colspan="1">67.7</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
</td><td rowspan="1" colspan="1">1.09 (d, 6.0)</td><td rowspan="1" colspan="1">18.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.13 (d, 6.0)</td><td rowspan="1" colspan="1">19.1</td></tr><tr><td rowspan="8" colspan="1">
<italic toggle="yes">N</italic>-Me-Leu_8</td><td rowspan="1" colspan="1">C<private-char name="DOUBLE BOND, LENGTH AS M-DASH" description="double bond, length as m-dash"><glyph-ref glyph-data="z.dbd"/></private-char>O</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">171.5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">171.5</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b1;</italic>
</td><td rowspan="1" colspan="1">5.15</td><td rowspan="1" colspan="1">53.2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5.16</td><td rowspan="1" colspan="1">53.2</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
<sub>a</sub>
</td><td rowspan="1" colspan="1">1.69</td><td rowspan="2" colspan="1">37.2</td><td rowspan="1" colspan="1">3.02 (<italic toggle="yes">N</italic>-Me Leu_8)</td><td rowspan="1" colspan="1">1.70 (m)</td><td rowspan="2" colspan="1">37.3</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b2;</italic>
<sub>b</sub>
</td><td rowspan="1" colspan="1">1.52</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.54 (m)</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b3;</italic>
</td><td rowspan="1" colspan="1">1.45</td><td rowspan="1" colspan="1">24.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.46 (m)</td><td rowspan="1" colspan="1">24.2</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b4;</italic>
</td><td rowspan="1" colspan="1">0.81 (d, 6.8)</td><td rowspan="1" colspan="1">20.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.81 (d, 6.8)</td><td rowspan="1" colspan="1">20.5</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">&#x003b5;</italic>
</td><td rowspan="1" colspan="1">0.87 (d, 6.8)</td><td rowspan="1" colspan="1">22.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.89 (d, 6.8)</td><td rowspan="1" colspan="1">18.8</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">N</italic>-Me</td><td rowspan="1" colspan="1">3.02 (s)</td><td rowspan="1" colspan="1">30.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3.02 (s)</td><td rowspan="1" colspan="1">30.7</td></tr><tr><td rowspan="22" colspan="1">Acyl chain</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">170.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">170.4</td></tr><tr><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">130.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">130.9</td></tr><tr><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">6.25 (d, 9.0)</td><td rowspan="1" colspan="1">136.2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">6.25 (d, 9.0)</td><td rowspan="1" colspan="1">136.2</td></tr><tr><td rowspan="1" colspan="1">4a/b</td><td rowspan="1" colspan="1">2.21</td><td rowspan="1" colspan="1">27.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.21</td><td rowspan="1" colspan="1">27.7</td></tr><tr><td rowspan="1" colspan="1">5a<italic toggle="yes">/</italic>b</td><td rowspan="1" colspan="1">2.15</td><td rowspan="1" colspan="1">31.2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.15</td><td rowspan="1" colspan="1">31.2</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">5.51 (dd, 14.8, 9.0)</td><td rowspan="1" colspan="1">131.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5.51 (dd, 14.8, 9.0)</td><td rowspan="1" colspan="1">131.7</td></tr><tr><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">6.02 (d, 14.8)</td><td rowspan="1" colspan="1">130.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">6.02 (d, 14.8)</td><td rowspan="1" colspan="1">130.7</td></tr><tr><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">6.04 (d, 14.8)</td><td rowspan="1" colspan="1">130.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">6.04 (d, 14.8)</td><td rowspan="1" colspan="1">130.7</td></tr><tr><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">5.70 (dd, 14.8, 9.0)</td><td rowspan="1" colspan="1">134.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5.70 (dd, 14.8, 9.0)</td><td rowspan="1" colspan="1">134.9</td></tr><tr><td rowspan="1" colspan="1">10a/b</td><td rowspan="1" colspan="1">2.14</td><td rowspan="1" colspan="1">32.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.14 (m)</td><td rowspan="1" colspan="1">32.0</td></tr><tr><td rowspan="1" colspan="1">11a/b</td><td rowspan="1" colspan="1">2.16</td><td rowspan="1" colspan="1">31.2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.16 (m)</td><td rowspan="1" colspan="1">31.2</td></tr><tr><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">5.55 (dd, 14.8, 9.0)</td><td rowspan="1" colspan="1">131.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5.55 (dd, 14.8, 9.0)</td><td rowspan="1" colspan="1">131.7</td></tr><tr><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">6.03 (d, 14.8)</td><td rowspan="1" colspan="1">130.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">6.03 (d, 14.8)</td><td rowspan="1" colspan="1">130.7</td></tr><tr><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">6.14 (d, 10.9)</td><td rowspan="1" colspan="1">130.2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">6.14 (d, 10.9)</td><td rowspan="1" colspan="1">130.2</td></tr><tr><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">6.14 (d, 10.9)</td><td rowspan="1" colspan="1">132.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">6.14 (d, 10.9)</td><td rowspan="1" colspan="1">132.7</td></tr><tr><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">6.16 (d, 14.8)</td><td rowspan="1" colspan="1">134.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">6.16 (d, 14.8)</td><td rowspan="1" colspan="1">134.6</td></tr><tr><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">5.57 (dd, 14.8, 9.0)</td><td rowspan="1" colspan="1">126.8</td><td rowspan="1" colspan="1">3.30 (C19&#x02013;acyl chain)</td><td rowspan="1" colspan="1">5.57 (dd, 14.8, 9.0)</td><td rowspan="1" colspan="1">126.8</td></tr><tr><td rowspan="1" colspan="1">18a</td><td rowspan="2" colspan="1">2.34</td><td rowspan="2" colspan="1">37.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.60 (m)</td><td rowspan="2" colspan="1">37.4</td></tr><tr><td rowspan="1" colspan="1">18b</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.34 (m)</td></tr><tr><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">3.30</td><td rowspan="1" colspan="1">47.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3.54</td><td rowspan="1" colspan="1">52.7</td></tr><tr><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">1.22 (d, 6.8)</td><td rowspan="1" colspan="1">17.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.27 (d, 6.8)</td><td rowspan="1" colspan="1">17.3</td></tr><tr><td rowspan="1" colspan="1">2-Me</td><td rowspan="1" colspan="1">1.76 (s)</td><td rowspan="1" colspan="1">12.1</td><td rowspan="1" colspan="1">2.21 (C4&#x02013;acyl chain); 7.01 (NH&#x02013;Ile_1)&#x02009;</td><td rowspan="1" colspan="1">1.76 (s)</td><td rowspan="1" colspan="1">12.0</td></tr></tbody></table></table-wrap><p>Heteronuclear single quantum coherence spectroscopy (HSQC) experiments revealed several cross peaks between 5.5 and 6.5 ppm (H) and 126 and 136 ppm (C). With the help of homonuclear Correlation Spectroscopy (COSY) and Total Correlated Spectroscopy (TOCSY) experiments, these signals were associated with a C<sub>20</sub> polyketide chain containing six double bonds: starting from the acyl group (C1), we could identify a methylated double bond (C2&#x02013;C3 methylated in C2), two methylenes (C4&#x02013;C5), two conjugated double bonds (C6 to C9), two further methylenes (C10&#x02013;C11), a triene system (C12 to C17) and a methylene (C18) (Fig. S8<xref rid="fn1" ref-type="fn">&#x02020;</xref>). The proton at 3.30 ppm, belonging to the C19 methine, showed COSY correlation with the terminal methyl group (C20) at 1.22 ppm and with the C18 methylene group at 2.34 ppm (Fig. S7B<xref rid="fn1" ref-type="fn">&#x02020;</xref>). The chemical shift of the corresponding carbon (47.9 ppm, C19) was compatible with an amine functionalization. We also observed eight <sup>3</sup><italic toggle="yes">J</italic><sub>H,H</sub> coupling constants of about 15 Hz and two of 11 Hz (<xref rid="tab2" ref-type="table">Table 2</xref>). This indicated an <italic toggle="yes">E</italic> stereochemistry at all double bonds except for the one at C14&#x02013;C15, which has a <italic toggle="yes">Z</italic> configuration. This was confirmed by a <italic toggle="yes">J</italic>-Resolved Spectroscopy (JRES) NMR experiment (Fig. S9<xref rid="fn1" ref-type="fn">&#x02020;</xref>). The methyl at C2 shows a strong NOE cross peak with the Ile amide at 7.01 (Fig. S8A and B<xref rid="fn1" ref-type="fn">&#x02020;</xref>), which suggests an <italic toggle="yes">E</italic> configuration of the C2&#x02013;C3 double bond, with the methyl at C2 and the proton at C3 on the opposite side of the double bond. The configuration of C19 could not be assigned from spectroscopic data. However, biosynthetic considerations (see below) suggest an <italic toggle="yes">S</italic> configuration. Overall, these analyses established the structure of the polyketide portion of allopeptimicins as a C<sub>20</sub> chain carrying an amino group at C19 and three unsaturation systems (<xref rid="fig2" ref-type="fig">Fig. 2</xref>).</p><fig position="float" id="fig2"><label>Fig. 2</label><caption><title>Structure of allopeptimicin congeners. In red stereocenters configuration inferred by bioinformatic analysis are reported.</title></caption><graphic xlink:href="d2ra02094g-f2" position="float"/></fig><p>Elucidating the structure of the peptide portion required substantially more effort. In the 0&#x02013;5.5 ppm portion of the proton spectrum, we could recognize spin systems belonging to one isoleucine (or <italic toggle="yes">allo</italic>-Ile; see below), one valine, two threonines, an <italic toggle="yes">N</italic>-methyl-leucine and two piperazic acids (Piz). A spin system containing a C&#x003b1; carbon at 73.3 ppm (<italic toggle="yes">&#x003b4;</italic><sub>C</sub>) was consistent with an &#x003b1;-hydroxy acid, and COSY and TOCSY correlations demonstrated that it was part of a 2-hydroxy,4-methyl-glutaric acid (Hmg) moiety. The C&#x003b2; carbon of one threonine was at 70.9 ppm instead of the standard 67 ppm, suggesting that this carbon was constrained and probably involved in peptide cyclization. An olefinic CH signal at 6.96/145.6 ppm, which was not associated with the polyketide chain, was included in one of the Piz spin systems, indicating an unsaturation between C&#x003b4; and N&#x003b4;.</p><p>After adding H<sub>2</sub>O to the NMR sample, amide signals appeared and, by using Nuclear Overhauser Effect Spectroscopy (NOESY) experiments, we were able to connect few amino acids (Fig. S8<xref rid="fn1" ref-type="fn">&#x02020;</xref>). In particular, the amide signal at 7.00 ppm in the Ile spin system shows a correlation with both the methyl signal at 1.76 ppm (at C2 of the acyl chain) and the olefinic proton at 6.25 ppm (at C3 of the acyl chain), suggesting that Ile (or <italic toggle="yes">allo</italic>-Ile) is amidated with the C<sub>20</sub> acyl chain. Moreover, we observed NOE correlations between the Val amide at 7.58 ppm and the proton at 4.34 ppm (CH at C&#x003b1; of Ile or <italic toggle="yes">allo</italic>-Ile) and between the amide at 7.76 ppm in the threonine with a constrained C&#x003b2; and the signal at 4.16 ppm (CH at C&#x003b1; of Val). An additional correlation was seen between the amide signal at 7.73 ppm of the other threonine and the signal at 4.99 ppm (CH at C&#x003b1; of Hmg). These observations established the partial sequences acyl chain&#x02013;Ile(<italic toggle="yes">allo</italic>-Ile)&#x02013;Val&#x02013;Thr and Hmg&#x02013;Thr in the peptide.</p><p>As mentioned above, when allopeptimicins were exposed to alkaline conditions, all congeners released a fragment having <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 391 [M + H]<sup>+</sup>, together with a variable larger portion (Fig. S2A and B<xref rid="fn1" ref-type="fn">&#x02020;</xref>). When a 4 mg sample of the A + B complex was exposed to those conditions, the larger hydrolytic fragments showed the tricuspid UV absorption and thus carried the triene moiety, while the small hydrolytic product showed little UV absorption. The latter was purified and analyzed by HR-MSMS and NMR (Fig. S10 and S11<xref rid="fn1" ref-type="fn">&#x02020;</xref>), providing a calculated molecular formula for <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 391.2046 [M + H]<sup>+</sup> of C<sub>17</sub>H<sub>31</sub>N<sub>2</sub>O<sub>8</sub> (<xref rid="tab1" ref-type="table">Table 1</xref>). 1D- and 2D-NMR experiments demonstrated the presence of five methyl groups (one on a nitrogen), two methylene groups and six methines (two on oxygens). It was possible to recognize the spin systems of Hmg, Thr and <italic toggle="yes">N</italic>-MeLeu, in accordance with the molecular formula and with the fragments observed by HR-MSMS (Fig. S10<xref rid="fn1" ref-type="fn">&#x02020;</xref>). In particular, the fragment at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 146.1158 [M + H]<sup>+</sup> corresponding to a C<sub>7</sub>H<sub>16</sub>NO<sub>2</sub><sup>+</sup> is consistent with a hydrated <italic toggle="yes">N</italic>-methyl leucine, suggesting that this amino acid is at the C-terminal position of the 391 amu fragment. Overall, these data are consistent with the hydrolytic fragment having the sequence Hmg&#x02013;Thr&#x02013;MeLeu and being released by hydrolysis of two ester bonds. The only way to fit the smaller hydrolytic fragment is by connecting the Hmg &#x003b1;-hydroxyl and C-terminus to a carboxyl group and a threonine hydroxyl, respectively, in the larger hydrolytic fragments, establishing the peptide sequence as Ile(<italic toggle="yes">allo</italic>-Ile)&#x02013;Val&#x02013;Thr&#x02013;Piz&#x02013;Piz&#x02013;Hmg&#x02013;Thr&#x02013;MeLeu.</p><p>By deeply analyzing the NMR data acquired for the A congeners mixture, we observed that the protons related to the unsaturated Piz spin system integrated to lower values than those of the other Piz residue, suggesting that the 2 amu difference and one lesser acetylation site of congeners A2 and A4 with respect to A1 and A3 are due to the unsaturation at C&#x003b4;&#x02013;N&#x003b4; of one of the Piz moieties. Similarly, the isoleucine-related signals appeared to be weaker than those of the other amino acids, while the valine spin system seemed to be splitted in two. This phenomenon could be reasonably associated with the A3 and A4 congeners having an isoleucine as the first amino acid followed by a valine, while two consecutive valines are present in A1 and A2.</p><p>With insights from the hydrolytic fragment and the NMR analysis of the A congeners, we were able to interpret the HR-MSMS data (Fig. S12 and S13<xref rid="fn1" ref-type="fn">&#x02020;</xref>). In particular, the most intense fragments <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 613.3173 [M + H]<sup>+</sup> and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 847.5410 [M + H]<sup>+</sup> are consistent with the two consecutive Piz located between acyl chain&#x02013;Ile(<italic toggle="yes">allo</italic>-Ile)&#x02013;Val&#x02013;Thr and Hmg&#x02013;Thr&#x02013;MeLeu moieties. Moreover, comparison between the fragments originating from A1 and A3 shows that the extra methylene difference must be in the N terminal amino acid, compatible with the first amino acid being a Val in A1 and an isoleucine in A3. In addition, the fragmentations of A1 and A2 indicates that the unsaturation is present on Piz5.</p><p>For establishing the stereochemistry of the amino-acid building blocks, we resorted to Marfey's method.<sup><xref rid="cit17" ref-type="bibr">17</xref></sup> Both threonine residues were found to be <sc>d</sc>-<italic toggle="yes">allo</italic>-Thr while valine was in <sc>l</sc>-configuration. Unfortunately, we were not able to distinguish <sc>l</sc>-Ile from <sc>l</sc>-<italic toggle="yes">allo</italic>-Ile (Fig. S14<xref rid="fn1" ref-type="fn">&#x02020;</xref>) and, due to the lack of adequate standards, we could not assign the stereochemistry to the remaining stereocenters: one in each of the piperazic acid moieties and two in Hmg moiety. However, analysis of the allopeptimicin BGC suggested the possible stereochemistry of the remaining &#x003b1;-carbons and pointed to <italic toggle="yes">allo</italic>-Ile as the first amino acid residue.</p><p>Extensive 1D- and 2D-NMR experiments were also carried out on a sample containing a mixture of allopeptimicin B congeners, with minor amounts of the A congeners (<xref rid="tab2" ref-type="table">Table 2</xref>). The resulting spectra were almost identical to those obtained from the A congeners, except for a shift in few HSQC cross signals: the C19 proton and carbon signals shifted from 3.30 and 47.9 ppm to 3.54 and 52.7 ppm, respectively; the two C18 methylene protons (both at 2.34 ppm) were split in two different signals at 2.34 and 2.60 ppm, while the C18 carbon at 37.4 ppm remained unchanged (Fig. S15A<xref rid="fn1" ref-type="fn">&#x02020;</xref>); and the protons of the C20 methyl group (at 1.22 ppm in the A congeners) were shifted to 1.27 (see Fig. S15B<xref rid="fn1" ref-type="fn">&#x02020;</xref> which reports the overlap of TOCSY experiments from the two datasets and highlights the C18&#x02013;C20 spin system in B). These changes, together with the mass spectrometry evidence of the presence of a &#x02013;SO<sub>3</sub>H moiety and the absence of one acetylatable group in the B congeners, are compatible with the installation of a sulfamic acid on the primary amine at C19 (<xref rid="fig2" ref-type="fig">Fig. 2</xref>). Unfortunately, the fragmentation of the B congeners was not very informative, since the sulfamate moiety was split giving the mass of the corresponding A congener (data not shown).</p><p>In summary, the structures of allopeptimicins were established to be as reported in <xref rid="fig2" ref-type="fig">Fig. 2</xref>, with the B molecules arising from the cognate A congeners after installation of a sulfamate.</p></sec><sec><title>The allopeptimicin biosynthetic gene cluster (BGC)</title><p>We readily identified the candidate <italic toggle="yes">apt</italic> BGC from a draft genome sequence of <italic toggle="yes">Actinoallomurus</italic> sp. ID145808 by using antiSMASH platform (<uri xlink:href="https://antismash.secondarymetabolites.org/">https://antismash.secondarymetabolites.org/</uri>). The <italic toggle="yes">apt</italic> BGC is predicted to span 117 kbp and consists of 35 CDSs associated with allopeptimicin biosynthesis, regulation and resistance. To most of those CDSs we were able to assign a role on the basis of homology searches and to establish the probable boundaries of the <italic toggle="yes">apt</italic> cluster (<xref rid="tab3" ref-type="table">Table 3</xref>; <xref rid="fig3" ref-type="fig">Fig. 3A</xref>).</p><table-wrap position="float" id="tab3"><caption><title>
<italic toggle="yes">apt</italic> biosynthetic gene cluster and deduced function of each CDS</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">CDS<xref rid="tab3fna" ref-type="table-fn">a</xref></th><th rowspan="1" colspan="1">Size (aa)</th><th rowspan="1" colspan="1">Homolog<xref rid="tab3fnb" ref-type="table-fn">b</xref> [function, pathway (strain, accession number)]</th><th rowspan="1" colspan="1">Identity<xref rid="tab3fnc" ref-type="table-fn">c</xref></th><th rowspan="1" colspan="1">Proposed function</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">ORF1<sup>C</sup></td><td rowspan="1" colspan="1">548</td><td rowspan="1" colspan="1">None, [family 43 glycosylhydrolase, (<italic toggle="yes">Rugosimonospora africana</italic>, WP_203920346.1)]</td><td rowspan="1" colspan="1">60%</td><td rowspan="1" colspan="1">Probably outside cluster</td></tr><tr><td rowspan="1" colspan="1">ORF2<sup>C</sup></td><td rowspan="1" colspan="1">121</td><td rowspan="1" colspan="1">None, [hypothetical protein, (<italic toggle="yes">Microbispora</italic> sp. H11081, WP_169946706.1)]</td><td rowspan="1" colspan="1">42%</td><td rowspan="1" colspan="1">Probably outside cluster</td></tr><tr><td rowspan="1" colspan="1">AptA</td><td rowspan="1" colspan="1">474</td><td rowspan="1" colspan="1">QmnB [propionyl-CoA carboxylase subunit beta (<italic toggle="yes">Amycolatopsis orientalis</italic>, AFI57002.1)]</td><td rowspan="1" colspan="1">71%</td><td rowspan="1" colspan="1">Methylmalonyl-CoA supply</td></tr><tr><td rowspan="1" colspan="1">AptB</td><td rowspan="1" colspan="1">357</td><td rowspan="1" colspan="1">CmmSu [sulfotransferase, MM4550 (<italic toggle="yes">Streptomyces argenteolus</italic>, AGU42411.1)]</td><td rowspan="1" colspan="1">36%</td><td rowspan="1" colspan="1">Sulfotransfer</td></tr><tr><td rowspan="1" colspan="1">AptC<sup>C</sup></td><td rowspan="1" colspan="1">246</td><td rowspan="1" colspan="1">Hypothetical protein BZZ08_05504 [unknown (<italic toggle="yes">Streptomyces</italic> sp. MH60, PPS81433.1)]</td><td rowspan="1" colspan="1">31%</td><td rowspan="1" colspan="1">Unknown</td></tr><tr><td rowspan="1" colspan="1">AptD1</td><td rowspan="1" colspan="1">2743</td><td rowspan="1" colspan="1">HmtL [NRPS, himastatin (<italic toggle="yes">Streptomyces himastatinicus</italic>, CBZ42146.1)]</td><td rowspan="1" colspan="1">53%</td><td rowspan="1" colspan="1">Piz biosynthesis</td></tr><tr><td rowspan="1" colspan="1">AptE</td><td rowspan="1" colspan="1">399</td><td rowspan="1" colspan="1">ArtE [NAD(P)/FAD-dependent oxidoreductase, aurantimycin A, (<italic toggle="yes">Streptomyces aurantiacus</italic> JA 4570, WP_016638468.1)]</td><td rowspan="1" colspan="1">45%</td><td rowspan="1" colspan="1">Piz5 dehydrogenation</td></tr><tr><td rowspan="1" colspan="1">AptF1</td><td rowspan="1" colspan="1">3608</td><td rowspan="1" colspan="1">Cle6 [PKSI, mediomycin A (<italic toggle="yes">Kitasatospora mediocidica</italic>, AWC08660.1)]</td><td rowspan="1" colspan="1">57%</td><td rowspan="1" colspan="1">Polyketide skeleton</td></tr><tr><td rowspan="1" colspan="1">AptG<sup>C</sup></td><td rowspan="1" colspan="1">545</td><td rowspan="1" colspan="1">HitE, [ATP-dependent_aminoacyl-ACP_synthetase, itachimycin (<italic toggle="yes">Streptomyces scabrisporus</italic>, BAR73011.1)]</td><td rowspan="1" colspan="1">64%</td><td rowspan="1" colspan="1">Activates the &#x003b2;-amino acid starter and loads it onto AptH</td></tr><tr><td rowspan="1" colspan="1">AptH</td><td rowspan="1" colspan="1">86</td><td rowspan="1" colspan="1">Strop_2776 [PCP, salinilactam (<italic toggle="yes">Salinispora tropica</italic> CNB-440, ABP55218.1)]</td><td rowspan="1" colspan="1">61%</td><td rowspan="1" colspan="1">&#x003b2; amino acid starter-specific PCP</td></tr><tr><td rowspan="1" colspan="1">AptI<sup>C</sup></td><td rowspan="1" colspan="1">318</td><td rowspan="1" colspan="1">FlvK [ACP <italic toggle="yes">S</italic>-malonyltransferase, fluvirucin B2 (<italic toggle="yes">Actinomadura fulva</italic> subsp. <italic toggle="yes">indica</italic>, BBD71108.1)]</td><td rowspan="1" colspan="1">61%</td><td rowspan="1" colspan="1">&#x003b2; amino acid starter-specific transferase</td></tr><tr><td rowspan="1" colspan="1">AptJ</td><td rowspan="1" colspan="1">514</td><td rowspan="1" colspan="1">LobL [AMP-binding protein, lobosamide A (<italic toggle="yes">Micromonospora</italic> sp. RL09-050-HVF-A, ALA09365.1)]</td><td rowspan="1" colspan="1">66%</td><td rowspan="1" colspan="1">Adds amino acid to AptG-bound &#x003b2; amino acid starter</td></tr><tr><td rowspan="1" colspan="1">AptK</td><td rowspan="1" colspan="1">430</td><td rowspan="1" colspan="1">LobO [pyridoxal 5&#x02032;-phosphate (PLP)-dependent &#x003b2;-glutamate-&#x003b2;-decarboxylase, incednine (<italic toggle="yes">Streptomyces</italic> sp. ML694-90F3, BAP34709.1)]</td><td rowspan="1" colspan="1">63%</td><td rowspan="1" colspan="1">&#x003b2;-Glutamate decarboxylase</td></tr><tr><td rowspan="1" colspan="1">AptF2</td><td rowspan="1" colspan="1">7611</td><td rowspan="1" colspan="1">Cle6 [PKSI, mediomycin A, (<italic toggle="yes">Kitasatospora mediocidica</italic>, AWC08660.1)]</td><td rowspan="1" colspan="1">53%</td><td rowspan="1" colspan="1">Polyketide skeleton</td></tr><tr><td rowspan="1" colspan="1">AptL</td><td rowspan="1" colspan="1">316</td><td rowspan="1" colspan="1">VinJ [proline iminopeptidase, vicenistatin (<italic toggle="yes">Streptomyces halstedii</italic>, BAD08367.1)]</td><td rowspan="1" colspan="1">66%</td><td rowspan="1" colspan="1">Removal of alanyl-protecting group of &#x003b2; amino acid starter</td></tr><tr><td rowspan="1" colspan="1">AptM</td><td rowspan="1" colspan="1">231</td><td rowspan="1" colspan="1">QmnC [thioesterase, quartromicin A1 (<italic toggle="yes">Amycolatopsis orientalis</italic> AFI57003.1)]</td><td rowspan="1" colspan="1">59%</td><td rowspan="1" colspan="1">Thioester hydrolysis</td></tr><tr><td rowspan="1" colspan="1">AptF3</td><td rowspan="1" colspan="1">1778</td><td rowspan="1" colspan="1">AzlB [PKSI, azalomycin F3a (<italic toggle="yes">Streptomyces</italic> sp. 211726, ARM20277.1)]</td><td rowspan="1" colspan="1">55%</td><td rowspan="1" colspan="1">Polyketide skeleton</td></tr><tr><td rowspan="1" colspan="1">AptD2</td><td rowspan="1" colspan="1">4587</td><td rowspan="1" colspan="1">CDA peptide synthetase I [NRPS, CDA (<italic toggle="yes">Streptomyces rochei</italic>, ALV82356.1)]</td><td rowspan="1" colspan="1">41%</td><td rowspan="1" colspan="1">Peptide skeleton</td></tr><tr><td rowspan="1" colspan="1">AptD3</td><td rowspan="1" colspan="1">3280</td><td rowspan="1" colspan="1">HmtL [NRPS, himastatin (<italic toggle="yes">Streptomyces himastatinicus</italic> ATCC 53653, CBZ42146.1)]</td><td rowspan="1" colspan="1">44%</td><td rowspan="1" colspan="1">Peptide skeleton</td></tr><tr><td rowspan="1" colspan="1">AptN<sup>C</sup></td><td rowspan="1" colspan="1">207</td><td rowspan="1" colspan="1">DUF2154 domain-containing protein [unknown (<italic toggle="yes">Actinomadura latina</italic>, WP_168444816.1)]</td><td rowspan="1" colspan="1">72%</td><td rowspan="1" colspan="1">Cell wall-active antibiotics response protein</td></tr><tr><td rowspan="1" colspan="1">AptO</td><td rowspan="1" colspan="1">454</td><td rowspan="1" colspan="1">HmtM [lysine <italic toggle="yes">N</italic>(6)-hydroxylase/<sc>l</sc>-ornithine <italic toggle="yes">N</italic>(5)-oxygenase, himastatin (<italic toggle="yes">Streptomyces himastatinicus</italic> ATCC 53653, CBZ42147.1)]</td><td rowspan="1" colspan="1">59%</td><td rowspan="1" colspan="1">Piz formation</td></tr><tr><td rowspan="1" colspan="1">AptP</td><td rowspan="1" colspan="1">238</td><td rowspan="1" colspan="1">MfnJ [negative transcriptional regulator, marformycin A (<italic toggle="yes">Streptomyces drozdowiczii</italic>, AJV88382.1)]</td><td rowspan="1" colspan="1">49%</td><td rowspan="1" colspan="1">Piz formation</td></tr><tr><td rowspan="1" colspan="1">AptQ</td><td rowspan="1" colspan="1">486</td><td rowspan="1" colspan="1">MakD1 [acyl CoA synthetase, maklamicin (<italic toggle="yes">Micromonospora</italic> sp. GMKU326, BAQ25518.1)]</td><td rowspan="1" colspan="1">32%</td><td rowspan="1" colspan="1">Activates glutaric acid or derivatives thereof</td></tr><tr><td rowspan="1" colspan="1">AptS</td><td rowspan="1" colspan="1">362</td><td rowspan="1" colspan="1">None [NAD-dependent malic enzyme, unknown (<italic toggle="yes">Actinomadura latina</italic>, NKZ08311.1)]</td><td rowspan="1" colspan="1">77%</td><td rowspan="1" colspan="1">Keto reduction during Hmg formation</td></tr><tr><td rowspan="1" colspan="1">AptT</td><td rowspan="1" colspan="1">261</td><td rowspan="1" colspan="1">Sky 33 [thioesterase type II, skyllamycin A (<italic toggle="yes">Streptomyces</italic> sp. Acta 2897, AEA30276.1)]</td><td rowspan="1" colspan="1">53%</td><td rowspan="1" colspan="1">Thioester hydrolysis</td></tr><tr><td rowspan="1" colspan="1">AptU</td><td rowspan="1" colspan="1">546</td><td rowspan="1" colspan="1">Pmet [<italic toggle="yes">P</italic>-methyltransferase, phosphinothricintripeptide (<italic toggle="yes">Streptomyces viridochromogenes</italic>, CAJ14051.1)]</td><td rowspan="1" colspan="1">42%</td><td rowspan="1" colspan="1">Methylation during Hmg formation</td></tr><tr><td rowspan="1" colspan="1">AptR1</td><td rowspan="1" colspan="1">913</td><td rowspan="1" colspan="1">AWR88389.1 [LuxR family transcriptional regulator, auroramycin (<italic toggle="yes">Streptomyces filamentosus</italic>, AWR88389.1)]</td><td rowspan="1" colspan="1">41%</td><td rowspan="1" colspan="1">Regulatory</td></tr><tr><td rowspan="1" colspan="1">AptV</td><td rowspan="1" colspan="1">124</td><td rowspan="1" colspan="1">DsaE [ketosteroid_isomerase, desotamide (<italic toggle="yes">Streptomyces scopuliridis</italic>, AJW76707.1)]</td><td rowspan="1" colspan="1">68%</td><td rowspan="1" colspan="1">
<sc>l</sc>-<italic toggle="yes">allo</italic>-Ile synthesis</td></tr><tr><td rowspan="1" colspan="1">AptW</td><td rowspan="1" colspan="1">360</td><td rowspan="1" colspan="1">DsaD [branched_chain_amino_acid_aminotransferase, desotamide (<italic toggle="yes">Streptomyces scopuliridis</italic>, AJW76706.1)]</td><td rowspan="1" colspan="1">71%</td><td rowspan="1" colspan="1">
<sc>l</sc>-<italic toggle="yes">allo</italic>-Ile synthesis</td></tr><tr><td rowspan="1" colspan="1">AptR2</td><td rowspan="1" colspan="1">139</td><td rowspan="1" colspan="1">AsuR4 [transcriptional regulator, asukamycin (<italic toggle="yes">Streptomyces nodosus</italic> subsp. <italic toggle="yes">asukaensis</italic>, ADI58623.1)]</td><td rowspan="1" colspan="1">50%</td><td rowspan="1" colspan="1">Regulatory</td></tr><tr><td rowspan="1" colspan="1">AptX<sup>C</sup></td><td rowspan="1" colspan="1">77</td><td rowspan="1" colspan="1">STRAU_RS01625 [MbtH family protein, aurantimycin A (<italic toggle="yes">Streptomyces aurantiacus</italic> JA 4570, WP_016638464.1)]</td><td rowspan="1" colspan="1">73%</td><td rowspan="1" colspan="1">MbtH-like protein</td></tr><tr><td rowspan="1" colspan="1">AptR3<sup>C</sup></td><td rowspan="1" colspan="1">342</td><td rowspan="1" colspan="1">DtpR2 [streptomycin biosynthesis operon regulator, thiolutin (<italic toggle="yes">Saccharothrix algeriensis</italic>, AJI44174.1)]</td><td rowspan="1" colspan="1">48%</td><td rowspan="1" colspan="1">Regulatory</td></tr><tr><td rowspan="1" colspan="1">AptZ1</td><td rowspan="1" colspan="1">326</td><td rowspan="1" colspan="1">STRAU_RS01670 [ATP-binding cassette domain-containing protein, aurantimycin A (<italic toggle="yes">Streptomyces aurantiacus</italic> JA 4570, WP_016638473.1)]</td><td rowspan="1" colspan="1">63%</td><td rowspan="1" colspan="1">Transporter</td></tr><tr><td rowspan="1" colspan="1">AptZ2</td><td rowspan="1" colspan="1">258</td><td rowspan="1" colspan="1">AGZ15463.1 [ABC transporter, polyoxypeptin (<italic toggle="yes">Streptomyces</italic> sp. MK498-98F14, AGZ15463.1)]</td><td rowspan="1" colspan="1">44%</td><td rowspan="1" colspan="1">Transporter</td></tr><tr><td rowspan="1" colspan="1">AptR4<sup>C</sup></td><td rowspan="1" colspan="1">224</td><td rowspan="1" colspan="1">AWW87431.1 [response regulator, reedsmycins (<italic toggle="yes">Streptomyces</italic> sp., AWW87431.1)]</td><td rowspan="1" colspan="1">47%</td><td rowspan="1" colspan="1">Regulatory</td></tr></tbody></table><table-wrap-foot><fn id="tab3fna"><label>a</label><p>Suffix C denotes complementary strand.</p></fn><fn id="tab3fnb"><label>b</label><p>Sequences with the highest BLAST score from the MIBIG database of validated biosynthetic gene clusters<sup><xref rid="cit35" ref-type="bibr">35</xref></sup> or from the non-redundant GenBank database (no protein name; in italics).</p></fn><fn id="tab3fnc"><label>c</label><p>% identity of the best matching sequence(s).</p></fn></table-wrap-foot></table-wrap><fig position="float" id="fig3"><label>Fig. 3</label><caption><title>(A) The allopeptimicin biosynthetic gene cluster, <italic toggle="yes">apt</italic>. The predicted functions for the open reading frames within the cluster are color-coordinated with the different panels. (B) Proposed biosynthetic pathway for piperazic acid (Piz) (pink rectangle), <sc>l</sc>-<italic toggle="yes">allo</italic>-Ile (light blue rectangle) and the &#x003b2;-amino acid starter unit (red rectangle) with the individual steps catalyzed by <italic toggle="yes">apt</italic> enzymes. (C) Domain arrangement and predicted biosynthetic intermediate for each PKS and NRPS polypeptide in the cluster, color-coordinated with the chemical structure. The black star indicates the AT domain recognizing a methylmalonate unit.</title></caption><graphic xlink:href="d2ra02094g-f3" position="float"/></fig><p>Consistent with the chemical structure, the <italic toggle="yes">apt</italic> BGC was found to encode three large polyketide synthases (PKS) for a total of eight modules and three non-ribosomal peptide synthetases (NRPSs) for additional eight modules. Moreover, there are the gene products needed for the synthesis of four specialized precursors and for the conversion of the A into B congeners (<xref rid="tab3" ref-type="table">Table 3</xref>; <xref rid="fig3" ref-type="fig">Fig. 3A</xref>). In addition, one end of the BGC encodes regulators and transporters.</p></sec><sec><title>Biosynthesis of the polyketide chain</title><p>The linear acyl chain of allopeptimicins contains an amine at C19, which would be consistent with a nitrogen-containing starter unit for the polyketide chain. Remarkably, the <italic toggle="yes">apt</italic> BGC contains a five-gene cassette (<italic toggle="yes">aptGHIJK</italic>) and an additional gene (<italic toggle="yes">aptL</italic>) with strong matches to genes coding for enzymes (<xref rid="tab3" ref-type="table">Table 3</xref>; <xref rid="fig3" ref-type="fig">Fig. 3A and B</xref>) involved in the formation and processing of the &#x003b2;-amino acid starter unit during macrolactam biosynthesis.<sup><xref rid="cit18" ref-type="bibr">18</xref></sup> After formation of the &#x003b2;-amino acid starter unit (see below), a stand-alone adenylation (A) domain selectively recognizes it and loads it onto a stand-alone peptidyl carrier protein (PCP). The amino group is then protected with <sc>l</sc>-alanine by another ATP-dependent ligase, followed by transfer onto the PKS starting module by a dedicated transferase. The alanyl-protecting group is eventually removed by a peptidase during or after polyketide elongation.<sup><xref rid="cit18" ref-type="bibr">18,19</xref></sup> AptG, AptH, AptI, AptJ and AptL are highly related (61 to 66% identity) to stand-alone A domains, PCPs, transferases, ATP-dependent ligases and oligopeptidases, respectively, from macrolactam BGCs (<xref rid="tab3" ref-type="table">Table 3</xref>). In addition, AptK shows 63% identity to the PLP-dependent &#x003b2;-glutamate-&#x003b2;-decarboxylase from the incednine BGC.<sup><xref rid="cit20" ref-type="bibr">20</xref></sup> Of note, it has been demonstrated in macrolactams that the specificity for selecting the appropriate starter unit is due to the size of the amino acid side chain present at a critical position in the stand-alone A domain (position 220 in IdnL1).<sup><xref rid="cit21" ref-type="bibr">21</xref></sup> The presence of Leu220 in AptG as in IdnL1 suggests (<italic toggle="yes">S</italic>)-3-aminobutyrate is the starter unit for allopeptimicin biosynthesis and that this configuration is retained at C19. By analogy with the incednine pathway, we speculate that &#x003b2;-glutamate originates from <sc>l</sc>-glutamate through the action of a glutamate-2,3-aminomutase.<sup><xref rid="cit21" ref-type="bibr">21</xref></sup> While the <italic toggle="yes">apt</italic> BGC does not encode such an enzyme, a protein with 74% identity to the IdnL4 glutamate-2,3-aminomutase is encoded elsewhere by the ID145808 chromosome (unpublished data). Overall, these data allow us to propose a pathway for polyketide chain initiation from a &#x003b2;-amino acid starter (<xref rid="fig3" ref-type="fig">Fig. 3B</xref>).</p><p>Preceding the <italic toggle="yes">aptGHIJK</italic> cassette is <italic toggle="yes">aptF1</italic>, encoding a PKS starting with an ACP domain and followed by three modules. Each module contains a dehydratase (DH) domain and all AT domains are predicted to be specific for malonate, based on computational sequence similarity. These features make AptF1 a likely candidate for elongating the 3-amino butyrate starter (transferred onto the N-terminal PCP by AptI) through three malonate additions, followed by double bond formation after reduction and dehydration.</p><p>The C<sub>10</sub> intermediate polyketide chain formed by AptF1 would then be elongated by AptF2, which consists of four modules: based on sequence analysis all contain AT domains predicted to be specific for malonate, KR domains and DH domains, but only the first and last module possess ER domains, consistent with the presence of saturated bonds at C4&#x02013;C5 and at C10&#x02013;C11 in the final product and with two conjugated double bonds (<xref rid="fig2" ref-type="fig">Fig. 2</xref> and <xref rid="fig3" ref-type="fig">3C</xref>). The mono-modular AptF3 would then complete polyketide synthesis through the incorporation of a (2<italic toggle="yes">S</italic>)-methylmalonyl-CoA unit, as for the predicted specificity of its AT domain, and installation of a double bond by the consecutive action of a B-type KR domain<sup><xref rid="cit22" ref-type="bibr">22</xref></sup> and by a DH domain. No bioinformatic prediction could be made about the stereo-selectivity of the other KR domains, as no consensus residues for A and B type KR could be identified.<sup><xref rid="cit22" ref-type="bibr">22</xref></sup></p><p>Overall, the number of PKS modules, their domain arrangements and the predicted (stereo)specificities are consistent with collinearity between PKS modules and the structure of the C<sub>20</sub> polyketide chain. Both AptF1 and AptF2 are mostly related to Cle6 (modules 1&#x02013;3), a PKS involved in the synthesis of the giant linear polyketide mediomycin (<xref rid="tab3" ref-type="table">Table 3</xref>), which carries an amino group at the &#x003c9; position;<sup><xref rid="cit23" ref-type="bibr">23</xref></sup> while AptF3 is mostly related to module 1 from AzlB, a PKS involved in the formation of azalomycin.<sup><xref rid="cit24" ref-type="bibr">24</xref></sup></p></sec><sec><title>Peptide and amino acid synthesis</title><p>The eight <italic toggle="yes">apt</italic> NRPS modules are also organized in three polypeptides: AptD1, AptD2 and AptD3 (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). The likely candidate for elongating the polyketide chain is the tetra-modular AptD2, which consists of two C&#x02013;A&#x02013;T modules, followed by a C&#x02013;A&#x02013;T&#x02013;E module and terminating with C&#x02013;A. The predicted specificities of the first three A domains are Val, Val and Thr, which nicely matches the N-terminal portion of the octapeptide: Val(<sc>l</sc>-<italic toggle="yes">allo</italic>-Ile)&#x02013;Val&#x02013;Thr (<xref rid="fig3" ref-type="fig">Fig. 3C</xref>). In addition, the E domain present in the third module fits with the experimental observation of both threonines being in the <sc>d</sc>-<italic toggle="yes">allo</italic> configuration (Fig. S14<xref rid="fn1" ref-type="fn">&#x02020;</xref>). The amino acid incorporated by the fourth module could not be predicted bioinformatically.</p><p>The octapeptide chain is likely to be terminated by AptD3, a bimodular NRPS consisting of C&#x02013;A&#x02013;T&#x02013;E and C&#x02013;A&#x02013;MT&#x02013;T&#x02013;TE domains, with predicted specificities for Thr and Leu. This nicely fits with Thr7 epimerization at the &#x003b1;-carbon, <italic toggle="yes">N</italic>-methylation of Leu8 and TE-catalyzed ester formation between Leu8 and Thr3 to close the macrocycle (<xref rid="fig3" ref-type="fig">Fig. 3C</xref>).</p><p>By exclusion, the remaining three residues (Piz4, Piz5 and Hmg6) are likely to be incorporated by the fourth module of AptD2 and by the bimodular AptD1 that, overall, account for the expected three C, A and T domains, plus one E domain, but with an unusual arrangement (<xref rid="fig3" ref-type="fig">Fig. 3C</xref>): the second module in AptD1 lacks an A domain, which is present at the C-terminus of AptD2. The unusual domain organization of the second AptD1 module (C&#x02013;T) has been observed also in HmtI and in KtzE from the himastatin and kutznerides BGCs, respectively: in both cases it has been suggested that the C domain forms an ester linkage between the amino acid loaded onto the upstream T domain and a hydroxy-acid acceptor.<sup><xref rid="cit25" ref-type="bibr">25,26</xref></sup> The same may happen during allopeptimicin biosynthesis, with the second C domain in AptD1 forming an ester linkage between Piz and Hmg. The latter could either be activated by the last A domain of AptD1 or provided in trans by the free-standing A domain AptQ (see below). While the amino acids incorporated by the two A domain in AptD1 could not be bioinformatically predicted, they share 95% identity, suggesting they recognize the same amino acid, hence Piz. In summary, we could tentatively propose the peptide segments recognized by the different modules as shown in <xref rid="fig3" ref-type="fig">Fig. 3C</xref>, although experimental work will be necessary to establish the role of the individual domains.</p><p>The E domains present in the third and first module of AptD2 and AptD3, respectively, directing the epimerization are consistent with the presence of two <sc>d</sc>-configured threonine residues at positions 3 and 7. If the central module of AptD1 is involved in adding the second Piz residue to the peptide chain, the associated E domain would then epimerize Piz5. Assuming that Hmg is in the <sc>l</sc>-configuration, the cyclic peptide would consist of alternating <sc>l</sc>- and <sc>d</sc>-amino acids, a feature often found in many NRPS-made peptides.<sup><xref rid="cit27" ref-type="bibr">27</xref></sup></p><p>Synthesis of the non-proteinogenic amino acids <sc>l</sc>-<italic toggle="yes">allo</italic>-Ile and Piz can be accounted for by the gene cassettes <italic toggle="yes">aptVW</italic> and <italic toggle="yes">aptOP</italic>, respectively (<xref rid="fig3" ref-type="fig">Fig. 3A and B</xref>). In the desotamide pathway, <sc>l</sc>-<italic toggle="yes">allo</italic>-Ile arises from <sc>l</sc>-Ile through the action of the pyridoxal 5&#x02032;-phosphate-linked aminotransferase DsaD and the isomerase DsaE.<sup><xref rid="cit28" ref-type="bibr">28</xref></sup> Consistently, AptV and AptW show 64 and 70% identity with DsaD and DsaE, respectively (<xref rid="tab3" ref-type="table">Table 3</xref>). In the kutznerides pathway, Piz is formed from <sc>l</sc>-ornithine through the consecutive action of the FAD-dependent <italic toggle="yes">N</italic>-hydroxylase KtzI and the heme-dependent dehydratase KtzT.<sup><xref rid="cit26" ref-type="bibr">26,29</xref></sup> AptO and AptP display 58 and 49% identity with KtzI and KtzT, respectively (<xref rid="tab3" ref-type="table">Table 3</xref>). The unsaturation in Piz5 could result from the action of AptE, which shows 45% identity with ArtE, a FAD-dependent oxidoreductase from the aurantimycin BGC. Aurantimycin contains two Piz residues and the complex includes congeners with unsaturated Piz moieties.<sup><xref rid="cit30" ref-type="bibr">30</xref></sup> It remains to be established whether AptE acts on free Piz or after peptide synthesis.</p><p>While to our knowledge there is no description of a pathway to Hmg formation, the <italic toggle="yes">aptQSTU</italic> cassette, consisting of closely linked and likely translationally coupled genes, represents a likely candidate for it. AptS is a NADP-dependent oxidoreductase with 38&#x02013;77% identity to NAD-dependent malic enzymes, and thus may be involved in converting 2-ketoglutarate in the corresponding hydroxy form. AptU is a radical SAM methyltransferase, likely to install the 4-methyl group. The free-standing A domain AptQ might be involved in activating 2-ketoglutarate before further modifications or it might interact in trans with AptD1 (see above). A role for the free-standing thioesterase AptT remains to be established. Further work will be necessary to establish the individual roles of enzymes for Hmg biosynthesis.</p></sec><sec><title>Resistance determinants</title><p>The allopeptimicin B congeners carry a sulfate linked to the amine at C19 of the alkyl chain (<xref rid="fig2" ref-type="fig">Fig. 2</xref>). Close to the left-hand end of the <italic toggle="yes">apt</italic> BGC lies <italic toggle="yes">aptB</italic>, encoding a protein with 36% identity with CmmSu (<xref rid="tab3" ref-type="table">Table 3</xref>), the enzyme catalyzing <italic toggle="yes">O</italic>-sulfonation of the C6 side chain during biosynthesis of the carbapenem MM4550 in <italic toggle="yes">Streptomyces argenteolus</italic>.<sup><xref rid="cit31" ref-type="bibr">31</xref></sup> Given the observed sequence identity, AptB is likely involved in formation of an N&#x02013;S bond, thus transforming each A congener into the corresponding B form. Since the B congeners are devoid of activity (see also below), AptB is likely a self-protecting mechanism in <italic toggle="yes">Actinoallomurus</italic> sp. ID145808. An additional resistance determinant might be AptN, which shows 91% identity to members of DUF2154, a domain found in proteins responding to cell wall-active antibiotics in staphylococci, including YvqF, which is associated with glycopeptide resistance.<sup><xref rid="cit32" ref-type="bibr">32</xref></sup></p></sec><sec><title>Additional genes</title><p>Additional functions related to allopeptimicin biosynthesis are: AptX, a member of the MbtH family, small proteins often associated with NRPSs;<sup><xref rid="cit33" ref-type="bibr">33</xref></sup> AptA, highly related to the &#x003b2; subunit of propionyl-CoA carboxylase, and thus a potential source of methylmalonyl-CoA for the last PKS extension step; and the additional free-standing TE AptM, a feature often observed in PKS and NRPS BGCs.<sup><xref rid="cit34" ref-type="bibr">34</xref></sup> Finally, the <italic toggle="yes">apt</italic> BGC contains <italic toggle="yes">aptC</italic> as a single gene of unknown function (<xref rid="tab3" ref-type="table">Table 3</xref>).</p><p>While the left-hand end of the cluster is likely represented by <italic toggle="yes">aptA</italic>, the other end contains several regulatory and export genes: <italic toggle="yes">aptR1</italic>, encoding a member of the LuxR family of transcriptional regulators, and <italic toggle="yes">aptR2</italic>, with high similarity to a regulator from the asukamycin BGC, are located upstream and downstream, respectively, of the <italic toggle="yes">aptVW</italic><sc>l</sc>-<italic toggle="yes">allo</italic>-Ile synthesis cassette. After <italic toggle="yes">aptX</italic> there are genes encoding AptR3, another regulator of the LuxR family, and the ABC transporters AptZ1 and AptZ2 (<xref rid="tab3" ref-type="table">Table 3</xref>).</p></sec><sec><title>Bioactivity</title><p>Allopeptimicins A were found to be particularly active against staphylococci, streptococci and <italic toggle="yes">Clostridioides difficile</italic>, with MICs of &#x02264;0.06&#x02013;0.125 &#x003bc;g mL<sup>&#x02212;1</sup>. Activity was also detected against other Gram-positive bacteria, such as <italic toggle="yes">Bacillus subtilis</italic>, <italic toggle="yes">Micrococcus luteus</italic> and enterococci (<xref rid="tab4" ref-type="table">Table 4</xref>). Except for some activity against <italic toggle="yes">Helicobacter pylori</italic> (MIC 16 &#x003bc;g mL<sup>&#x02212;1</sup>), no activity was observed against other Gram-negative species (<xref rid="tab4" ref-type="table">Table 4</xref>) and against eukaryotic microorganisms (data not shown). In contrast, allopeptimicins B were totally inactive (<xref rid="tab4" ref-type="table">Table 4</xref>). In time-kill experiments with exponentially growing <italic toggle="yes">S. aureus</italic> ATCC 6538P, allopeptimicins A at 32 &#x003bc;g mL<sup>&#x02212;1</sup> effectively killed the bacteria within 3 hours (Fig. S16A<xref rid="fn1" ref-type="fn">&#x02020;</xref>).</p><table-wrap position="float" id="tab4"><caption><title>Antimicrobial activities of allopeptimicins A and B against selected bacterial species</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1">Strain<xref rid="tab4fna" ref-type="table-fn">a</xref></th><th colspan="3" rowspan="1">MIC (&#x003bc;g mL<sup>&#x02212;1</sup>)</th></tr><tr><th rowspan="1" colspan="1">Allopeptimicin A</th><th rowspan="1" colspan="1">Allopeptimicin B</th><th rowspan="1" colspan="1">VAN<xref rid="tab4fnb" ref-type="table-fn">b</xref></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus aureus</italic> ATCC6538P</td><td rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">0.25</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">S. aureus</italic> L3864 (MRSA)</td><td rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">0.5</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">S. epidermidis</italic> ATCC12228</td><td rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus pneumoniae</italic> L44</td><td rowspan="1" colspan="1">&#x02264;0.06</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">0.25</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">S. pyogenes</italic> L49</td><td rowspan="1" colspan="1">&#x02264;0.06</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">0.25</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Micrococcus luteus</italic> ATCC10240</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Bacillus subtilis</italic> 168 ATCC27370</td><td rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">0.25</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Enterococcus faecium</italic> L568</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">E. faecalis</italic> L559</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Clostridioides difficile</italic> 421 L4013</td><td rowspan="1" colspan="1">&#x02264;0.06</td><td rowspan="1" colspan="1">Nt</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Helicobacter pylori</italic> L4219</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">Nt</td><td rowspan="1" colspan="1">&#x0003e;128</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Pseudomonas aeruginosa</italic> ATCC27853</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">&#x0003e;128</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic> ATCC25922</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">&#x0003e;128</td><td rowspan="1" colspan="1">&#x0003e;128</td></tr></tbody></table><table-wrap-foot><fn id="tab4fna"><label>a</label><p>Strains designated with an L prefix are clinical isolates (collected in Italy or USA) from the NAICONS collection. Other strains are from public collections as indicated. American Type Culture Collection, USA.</p></fn><fn id="tab4fnb"><label>b</label><p>Vancomycin (VAN) used as control antibiotic.</p></fn></table-wrap-foot></table-wrap><p>We then investigated the effect of allopeptimicins A on macromolecular synthesis in <italic toggle="yes">S. aureus</italic> cells by monitoring the incorporation of labeled precursors (5-[<sup>3</sup>H] thymidine for DNA, [<sup>3</sup>H] uridine for RNA, <sc>l</sc>-[<sup>3</sup>H] tryptophan for protein and [<sup>3</sup>H] glucosamine for cell wall synthesis): we readily observed that cell wall biosynthesis was inhibited by 50% already at 1.6 &#x003bc;g mL<sup>&#x02212;1</sup> allopeptimicins A, while the concentrations inhibiting by 50% (IC<sub>50</sub>) were 5.7 &#x003bc;g mL<sup>&#x02212;1</sup> for DNA synthesis, 35 &#x003bc;g mL<sup>&#x02212;1</sup> for RNA synthesis and &#x0003e;50 &#x003bc;g mL<sup>&#x02212;1</sup> for protein synthesis, thus suggesting that cell wall synthesis is the primary target for this antibiotic (Fig. S16B<xref rid="fn1" ref-type="fn">&#x02020;</xref>). Consistently, when tested against different <italic toggle="yes">S. aureus</italic> mutants selected through serial passages, phenotypically and genotypically related to vancomycin insensitive <italic toggle="yes">S. aureus</italic> (VISA) strains,<sup><xref rid="cit36" ref-type="bibr">36</xref></sup> we observed an increase in the MIC of allopeptimicins A (Fig. S16c<xref rid="fn1" ref-type="fn">&#x02020;</xref>). Against these same mutants, a similar shift in MICs was observed for other <italic toggle="yes">bona fide</italic> antibiotics that bind to the essential peptidoglycan precursor lipid II such as vancomycin, ramoplanin and NAI-107.<sup><xref rid="cit36" ref-type="bibr">36</xref></sup></p></sec><sec><title>Self-defense mechanism in the producer strain <italic toggle="yes">Actinoallomurus</italic> sp. ID145808</title><p>The producer strain ID145808 was isolated from a soil sample collected in California (US). It was classified as <italic toggle="yes">Actinoallomurus</italic> on the basis of its 16S rRNA gene sequence, which shows 99% identity to the sequence from <italic toggle="yes">Actinoallomurus bryophytorum</italic>.</p><p>When ID145808 was grown in AF-AS medium, production of allopeptimicins started to be detectable at 72 h (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>) and remained essentially constant up to 120 h. During this period, congeners A and B were produced in similar amounts. Starting at 144 h, the production rate increased, with the A congeners reaching 115 mg L<sup>&#x02212;1</sup> at 240 h, while production of allopeptimicins B increased at a lower rate, leading to a final ratio of about 75&#x02009;:&#x02009;25 A&#x02009;:&#x02009;B (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>). Cultivation times longer than 240 h did not lead to increased production.</p><fig position="float" id="fig4"><label>Fig. 4</label><caption><title>Production of allopeptimicins without (A) and with (B) threonine supplementation. Values calculated as means of three replicates with standard deviation. Allopeptimicins A and B are indicated by blue and orange bars, respectively. The grey line indicates the total complex (A + B) observed.</title></caption><graphic xlink:href="d2ra02094g-f4" position="float"/></fig><p>Supplementing the medium with 1 g L<sup>&#x02212;1</sup><sc>l</sc>-threonine did not affect the early phases of production in terms of total allopeptimicins and A&#x02009;:&#x02009;B ratio (<xref rid="fig4" ref-type="fig">Fig. 4B</xref>). However, <sc>l</sc>-threonine supplementation afforded higher titers at 240 h and extended the production phase up to 288&#x02013;312 h, leading to 180 mg L<sup>&#x02212;1</sup>. <sc>l</sc>-Threonine supplementation did not alter the A&#x02009;:&#x02009;B ratio, which remained 3&#x02009;:&#x02009;1 at long incubation times.</p><p>Since congeners A possess antibacterial activity while congeners B do not, the switch in congener ratio upon prolonged cultivation prompted us to analyze the sensitivity of <italic toggle="yes">Actinoallomurus</italic> ID145808 <italic toggle="yes">versus</italic> its own products (Fig. S17<xref rid="fn1" ref-type="fn">&#x02020;</xref>). The growth of the producer strain was not affected by spotting increasing amounts of a sample of allopeptimicins B (which contained around 5% of A congeners), until a slight growth disturbance was observed when 50 &#x003bc;g were spotted on the plate. Conversely, 2 &#x003bc;g of the A congeners fully prevented growth, indicating that <italic toggle="yes">Actinoallomurus</italic> ID145808 is sensitive to the A congeners when growing on agar plates, a condition when visible colonies appear after 72&#x02013;96 h. We can thus hypothesize that formation of allopeptimicins B is a mechanism of self-protection. Since <italic toggle="yes">Actinoallomurus</italic> sp. ID145808 grows as large mycelial clumps in liquid medium, it is conceivable that non-dividing portions of a mycelial unit produce the active congeners while actively duplicating sectors express <italic toggle="yes">aptB</italic> to protect themselves. Further experiments need to be done to understand self-resistance in <italic toggle="yes">Actinoallomurus</italic> sp. ID145808.</p></sec></sec><sec><title>Conclusions</title><p>Allopeptimicins possess unusual structural features. Few examples exist of hybrid polyketide&#x02013;peptides carrying such a long and unsaturated acyl chain: the closest relative may be the anabaenolysins from the cyanobacterium <italic toggle="yes">Anabaena</italic>, which consist of a C<sub>18</sub> poly-unsaturated fatty acid that contributes three carbon atoms to a peptidic macrocycle.<sup><xref rid="cit37" ref-type="bibr">37</xref></sup> In addition, trienes with an <italic toggle="yes">E</italic>&#x02013;<italic toggle="yes">Z</italic>&#x02013;<italic toggle="yes">E</italic> configuration are rarely encountered: examples are represented by some colabomycin congeners<sup><xref rid="cit38" ref-type="bibr">38</xref></sup> from <italic toggle="yes">Streptomyces</italic>, and aurafuron B<sup><xref rid="cit39" ref-type="bibr">39</xref></sup> and spirangiens<sup><xref rid="cit40" ref-type="bibr">40</xref></sup> from myxobacteria. A sulfamate moiety has been observed only in metabolites from marine macroorganisms: some minalemine congeners from the tunicate <italic toggle="yes">Didemnum rodriguesi</italic>;<sup><xref rid="cit41" ref-type="bibr">41</xref></sup> scleritodermin from the lithistid sponge <italic toggle="yes">Scleritoderma nodosum</italic>;<sup><xref rid="cit42" ref-type="bibr">42</xref></sup> and some ianthesine congeners from the marine sponge <italic toggle="yes">Ianthella</italic> sp.<sup><xref rid="cit43" ref-type="bibr">43</xref></sup> To our knowledge, there is only one precedent for metabolite carrying an Hmg moiety: the D congeners of destruxins, hexadepsipeptides produced by <italic toggle="yes">Metarhizium anisopliae</italic><sup><xref rid="cit44" ref-type="bibr">44</xref></sup> and other soil fungi. All the above features, along with the uncommon presence of two ester bonds in a single macrocycle, make allopeptimicins truly unique metabolites.</p><p>The structural uniqueness of allopeptimicins is reflected in a complex BGC, with dedicated gene cassettes devoted to formation of specialized precursors and modular assembly lines related to those from different BGCs. Thus, the <italic toggle="yes">apt</italic> BGC is one more example of a BGC with a mosaic structure, a feature common to many BGCs.<sup><xref rid="cit4" ref-type="bibr">4,45</xref></sup> Several aspects of the allopeptimicin NRPS remain obscure, including how the Piz&#x02013;Piz&#x02013;Hmg portion is assembled.</p><p>Structurally, allopeptimicins A consist of a relatively rigid macrocycle with a long acyl chain with few rotatable bonds and terminating with a positive charge. The available evidence &#x02013; from macromolecular syntheses to reduced activity on VISA strains &#x02013; suggest that allopeptimicins A interfere with cell wall biosynthesis. It is tempting to speculate that the macrocycle interacts with some essential cell wall components near the bacterial membrane, while the acyl chain embeds into the membrane, with further ionic interactions between the negatively charged phospholipids and the amino group at C-19. Turning the positive into a negative charge through sulfamidation would abolish this interaction with total loss of activity. Not many precedents exist of metabolites whose activity is modulated by sulfation: a notable example is represented by the paralytic shellfish saxitoxins, in which <italic toggle="yes">O</italic>- and/or <italic toggle="yes">N</italic>-sulfation leads to a reduced toxicity.<sup><xref rid="cit46" ref-type="bibr">46</xref></sup> In any case, turning a positive into a negative charge by formation of a sulfamate represents one more example of the ingenuity of soil bacteria in devising mechanisms for self-protection.</p></sec><sec><title>Materials and method</title><sec><title>General experimental procedures</title><p>
<sup>1</sup>H and <sup>13</sup>C 1D and 2D NMR spectra (COSY, TOCSY, NOESY, HSQC, HMBC) were measured in CD<sub>3</sub>CN&#x02009;:&#x02009;D<sub>2</sub>O 8&#x02009;:&#x02009;2 with or without drops of H<sub>2</sub>O at 25 &#x000b0;C using a Bruker Avance II 300 MHz spectrometer. Mixing time for TOCSY and NOESY experiments was set at 0.06 and 0.4 seconds, respectively. LC-MS/MS analyses were performed on a Dionex UltiMate 3000 HPLC system coupled with an LCQ Fleet (Thermo Scientific) mass spectrometer equipped with an electrospray interface (ESI) and a tridimensional ion trap. The column was an Atlantis T3 C-18 5 &#x003bc;m &#x000d7; 4.6 mm &#x000d7; 50 mm maintained at 40 &#x000b0;C at a flow rate of 0.8 mL min<sup>&#x02212;1</sup>. Phase A was 0.05% trifluoroacetic acid (TFA), phase B was 100% acetonitrile. The elution was executed with a 14 min multistep program that consisted of 10, 10, 95, 95, 10 and 10% phase B at 0, 1, 7, 12, 12.5 and 14 min, respectively. UV-Vis signals (190&#x02013;600 nm) were acquired using the diode array detector. The <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> range was 110&#x02013;2000 and the ESI conditions were as follows: spray voltage of 3500 V, capillary temperature of 275 &#x000b0;C, sheath gas flow rate at 35 units and auxiliary gas flow rate at 15 units. High resolution MS spectra were recorded at Unitech OMICs (University of Milano, Italy) using a Dionex Ultimate 3000 HPLC system coupled with a Triple TOF&#x000ae; 6600 (Sciex) equipped with an ESI source. The experiments were carried using the same column and eluting system as described for low resolution LC-MS analysis. The ESI parameters were the following: curtain gas 25 units, ion spray voltage floating 5500 V, temperature 50 &#x000b0;C, ion source gas1 10 units, ion source gas2 0 units, declustering potential 80 V, syringe flow rate 10 &#x003bc;L min<sup>&#x02212;1</sup>, accumulation time 1 s.</p></sec><sec><title>Bacterial strains, growth and fermentation procedures</title><p>For metabolite analyses, 88 <italic toggle="yes">Actinoallomurus</italic> strains from the NAICONS collection were propagated from cryovials on BTT and S1 agar plates<sup><xref rid="cit47" ref-type="bibr">47</xref></sup> and incubated at 30 &#x000b0;C for <italic toggle="yes">ca.</italic> 14 d. Mycelium from BTT plates was inoculated into 15 mL of AF-A medium<sup><xref rid="cit12" ref-type="bibr">12</xref></sup> in 50 mL Erlenmeyer flask and incubated 72 h at 30 &#x000b0;C in a rotary shaker at 200 rpm. Then, 10% seed culture was transferred into 15 mL AF-A medium in 50 mL Falcon tube supplied with 1 g of 5 mm glass beads. After 7 d in a rotary shaker at 250 rpm and at 30 &#x000b0;C, cultures were harvested. Two different extracts were prepared from each culture: one by solvent extraction of the pelleted mycelium and one by solid-phase adsorption of the cleared broth, essentially as described.<sup><xref rid="cit8" ref-type="bibr">8</xref></sup> The 176 extracts generated were analyzed individually by transferring 500 &#x003bc;L in HPLC vials prior to drying.</p><p>For allopeptimicin production, 2 mL of a frozen mycelium stock of strain ID145808 was inoculated into 25 mL of AF-A medium in a 300 mL Erlenmeyer flask and incubated 72 h at 30 &#x000b0;C in a rotary shaker at 200 rpm. Then, 6 mL was transferred into 100 mL AF-AS medium (AF-A supplemented with 10 g L<sup>&#x02212;1</sup> soluble starch) in 500 mL flasks supplied with 10 g of 5 mm glass beads. Where required, 1 g L<sup>&#x02212;1</sup><sc>l</sc>-threonine (Sigma-Aldrich) was added from a filter-sterilized 50 mg mL<sup>&#x02212;1</sup> stock solution. The flasks were incubated at 30 &#x000b0;C, on a rotary shaker at 200 rpm. For allopeptimicin analysis, 0.5 mL was withdrawn from the production culture and transferred into 2 mL Eppendorf tubes containing 0.5 mL acetonitrile. Samples were kept at 40 &#x000b0;C under constant shaking (800 rpm) for 1 h, then centrifuged for 3 min at 13&#x02009;000 rpm. The supernatants were recovered and 500 &#x003bc;L were transferred into 1.5 mL HPLC vials for LC-MS/MS analysis.</p></sec><sec><title>Processing of LC-MS/MS data</title><p>.mzXML files from 176 <italic toggle="yes">Actinoallomurus</italic> extracts were processed with MZmine 2 v53 (ref. <xref rid="cit48" ref-type="bibr">48</xref>) as follows: (A) mass detection = retention time, auto; MS1 noise level, 1 &#x000d7; 10<sup>3</sup>; MS2 noise level, 1 &#x000d7; 10. (B) ADAP chromatogram builder = retention time, auto; MS-level, 1; min group size in no. of scans, 3; group intensity threshold, 5 &#x000d7; 10<sup>1</sup>; min highest intensity, 1 &#x000d7; 10<sup>1</sup>; <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> tolerance, 0.5 Da. (C) Chromatogram deconvolution = baseline-cutoff algorithm; min peak height, 1 &#x000d7; 10<sup>2</sup>; peak duration, 0.03&#x02013;1 min; baseline level, 1 &#x000d7; 10<sup>2</sup>; <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> range MS2 pairing, 5 Da; RT range MS2 pairing, 0.25 min. (D) Isotopic peaks grouper = <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> tolerance, 1 Da; RT tolerance, 0.25 min; monotonic shape, no; maximum charge, 2; representative isotope, most intense. (E) Join peak alignment = <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> tolerance, 1 Da; RT tolerance, 0.25 min; weight for <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>, 30; weight for RT, 70. (F) MS features with no accompanying MS2 data were excluded from the analysis. The resulting MS feature list was exported to the GNPS-compatible format, using the MS Feature-Based Molecular Networking (FBMN) workflow (version release_28.2) on GNPS.<sup><xref rid="cit5" ref-type="bibr">5</xref></sup></p><p>Parameters were adapted from the GNPS documentation as follows: MS2 spectra were filtered to remove all MS/MS fragment ions within &#x000b1;17 Da of the precursor <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> value; only the top six fragment ions in the &#x000b1;50 Da window through the spectrum were utilized, with a minimum fragment ion intensity of 50. The MS/MS fragment ion tolerance was set to 0.9 Da and the precursor ion mass tolerance was set to 2 Da. Edges of the created molecular network were filtered to have a cosine score above 0.5 and more than 2 matched peaks between the connected nodes, with a maximum of 10 neighbor nodes for one single node. The maximum size of clusters in the network was set to 50 and the maximum shift between precursors was set at 300 Da. The MS2 spectra in the molecular network were searched against GNPS spectral libraries. Reported matches between network and library spectra were required to have a score above 0.7 and at least 3 matched peaks. The molecular network was visualized using Cytoscape 3.9.0.<sup><xref rid="cit49" ref-type="bibr">49</xref></sup></p></sec><sec><title>Allopeptimicin purification</title><p>A 1 L, 312 h culture of strain ID145808 in AF-AS medium, containing 80 and 38 mg L<sup>&#x02212;1</sup> of A and B congeners, respectively, was centrifuged 10 min at 3500 rpm in 250 mL centrifuge bottles. The pellet was discarded while the cleared broth was pooled, brought to pH 4 with 5.5 mL 1 M HCl and extracted with 2 &#x000d7; 500 mL dichloromethane&#x02009;:&#x02009;methanol 8&#x02009;:&#x02009;2 in a 2 L separating funnel. The organic phase was dried under reduced pressure and the powder was washed twice with 5 mL H<sub>2</sub>O by transferring the suspension into a 15 mL Falcon tube, centrifuging 10 min at 4000 rpm and discarding the washing solution. Then, the pellet was dissolved in 5 mL dichloromethane and resolved using a CombiFlash RF (Teledyne ISCO) medium pressure chromatography system on a 24 g RediSep RF Silica flash column (Teledyne ISCO). Flow was 20 mL min<sup>&#x02212;1</sup>, phase A was dichloromethane and phase B was methanol. The column was previously conditioned with 100% phase A for 7 min, followed by a 21 min gradient to 60% phase A and kept at 60% phase A for 10 min. Fractions of 15 mL were collected and analyzed by LC-MS. Fractions with similar purity were pooled and dried under vacuum, yielding about 20 mg of a mixture of A congeners and 7 mg of a mixture of B congeners, the latter containing about 15% w/w A congeners. These samples were used for NMR characterization and for the sensitivity of <italic toggle="yes">Actinoallomurus</italic> ID145808 <italic toggle="yes">versus</italic> its own products. For bioactivity studies the A congeners mixture was used as such while the B mixture was further purified as follows: 1.5 mg of the powder were dissolved in 400 &#x003bc;L acetonitrile 60% and chromatographed using 20 analytical HPLC runs on a Dionex UltiMate 3000 HPLC system, using the same conditions as described for LC-MS analysis and collecting the fractions at 7.8 minutes. About 1 mg of pure allopeptimicin B congeners were achieved.</p></sec><sec><title>Chemical modifications of allopeptimicins</title><p>Reactions were performed on partially purified samples obtained from different fermentations containing a mixture of A and B congeners. Hydrolysis: a 4 mg sample (6&#x02009;:&#x02009;4 A&#x02009;:&#x02009;B) was dissolved in 1 mL 50% acetonitrile, then 1 mL 1 M NaOH was added. After 1 h stirring at room temperature (RT), 0.5 mL H<sub>2</sub>O was added to the reaction mix. After LC-MS analysis, the reaction mix was buffered to pH 7 by adding 1 M 0.5 mL HCl and resolved using a 5 g flash C18 Isolute SPE cartridge (Biotage). After loading the sample, the column was washed with 10 mL H<sub>2</sub>O, then eluted with 10 mL 30% acetonitrile, yielding a fraction containing the smaller hydrolysis product (with <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 391 [M + H]<sup>+</sup>), which was dried, dissolved in 0.5 mL D<sub>2</sub>O and analyzed by NMR. Acetylation: a 1 mg sample (6&#x02009;:&#x02009;4 A&#x02009;:&#x02009;B) was dissolved in 0.2 mL acetonitrile, then 0.2 mL acetic anhydride was added. The reaction was stirred 1 h at RT and then analyzed by LC-MS. Amidation: a 2 mg sample (4&#x02009;:&#x02009;6 A&#x02009;:&#x02009;B) was dissolved in 500 &#x003bc;L dry DMF and the pH adjusted to 8 by adding 2 &#x003bc;L methylamine. After adding 1 mg PyBOP, the mixture was stirred for 10 min at RT and analyzed by LC-MS. Stereochemistry determination: a sample of allopeptimicins (2 mg, 9&#x02009;:&#x02009;1 A&#x02009;:&#x02009;B) was treated as described,<sup><xref rid="cit17" ref-type="bibr">17</xref></sup> together with the following amino acid standards: <sc>l</sc>-Thr, <sc>d</sc>-Thr, <sc>l</sc>-<italic toggle="yes">allo</italic>-Thr, <sc>d</sc>-<italic toggle="yes">allo</italic>-Thr, <sc>l</sc>-Val, <sc>d</sc>-Val, <sc>l</sc>-Ile and <sc>l</sc>-<italic toggle="yes">allo</italic>-Ile, and then analyzed by LC-MS using a HiQ Sil C18 HS column (4.6 &#x000d7; 250 mm, Kya Tech Corporation, Japan). Phase A was 0.05% trifluoroacetic acid, phase B was acetonitrile. The samples were run using a gradient from 10 to 90% B in 45 min at a flow rate of 0.8 mL min<sup>&#x02212;1</sup>.</p></sec><sec><title>Antimicrobial assays</title><p>The antibacterial activity of extracts was determined as described.<sup><xref rid="cit16" ref-type="bibr">16</xref></sup> MICs were determined by micro-dilution according to the Clinical and Laboratory Standards Institute guidelines (<uri xlink:href="https://clsi.org">https://clsi.org</uri>).<sup><xref rid="cit50" ref-type="bibr">50</xref></sup> All aerobic strains were grown in M&#x000fc;ller Hinton broth containing 20 mg L<sup>&#x02212;1</sup> CaCl<sub>2</sub> and 10 mg L<sup>&#x02212;1</sup> MgCl<sub>2</sub> except for <italic toggle="yes">Streptococcus</italic> spp. and <italic toggle="yes">Haemophilus influenzae</italic>, which were grown in Todd&#x02013;Hewitt broth and Brain Hearth Infusion (with 0.5% yeast extract), respectively. Strains were inoculated at 1 &#x000d7; 10<sup>5</sup> CFU mL<sup>&#x02212;1</sup>. For <italic toggle="yes">Clostridioides difficile</italic>, fresh cultures were diluted to 1 &#x000d7; 10<sup>5</sup> CFU mL<sup>&#x02212;1</sup> with Brucella medium (BB) supplemented with hemin (5 &#x003bc;g mL<sup>&#x02212;1</sup>), vitamin K1 (1 &#x003bc;g mL<sup>&#x02212;1</sup>), lysed horse blood (5%) and Oxyrase&#x000ae; (1&#x02009;:&#x02009;25 v/v), while for <italic toggle="yes">Helicobacter pylori</italic> the strain was streaked twice on Brucella agar plates, then colonies were resuspended to an OD<sub>600</sub> of 0.8 and diluted 1&#x02009;:&#x02009;10 with BB containing 3% calf bovine serum. Bacteria were incubated at 37 &#x000b0;C for 24 h except for <italic toggle="yes">C. difficile</italic> (48 h) and <italic toggle="yes">H. pylori</italic> (72 h). Allopeptimicins were dissolved at 10 mg mL<sup>&#x02212;1</sup> in dimethyl sulfoxide, while vancomycin, used as control, was dissolved in water. Samples were diluted with the test medium to the required concentrations.</p><p>Time-kill curves were performed as previously described<sup><xref rid="cit51" ref-type="bibr">51</xref></sup> using <italic toggle="yes">S. aureus</italic> ATCC 6538P. Growth kinetics was performed under the same conditions as MICs and recording OD<sub>600</sub> every hour in a Synergy 2 reader (Biotek).</p><p>For evaluating the activity against strain ID145808, serial dilutions in 60% methanol were prepared from stock solutions of allopeptimicins A (2 mg mL<sup>&#x02212;1</sup>) and B (5 mg mL; this preparation contained 5% A congeners). Then, 10 &#x003bc;L of appropriate dilutions were spotted onto BTT agar plates, which had been previously seeded with strain ID145808. Positive and negative controls were 10 &#x003bc;g mL<sup>&#x02212;1</sup> apramycin and 60% methanol, respectively. Plates were incubated at 30 &#x000b0;C for 10 days before scoring inhibition haloes.</p></sec><sec><title>Macromolecular synthesis</title><p>The effect on macromolecular synthesis was tested by monitoring the incorporation of labeled precursors: 5-[<sup>3</sup>H] thymidine for DNA, [<sup>3</sup>H] uridine for RNA, <sc>l</sc>-[<sup>3</sup>H] tryptophan for protein and [<sup>3</sup>H] glucosamine hydrochloride for cell wall synthesis as described.<sup><xref rid="cit52" ref-type="bibr">52</xref></sup></p></sec><sec><title>Bioinformatic analyses</title><p>From a draft genome sequence of <italic toggle="yes">Actinoallomurus</italic> sp. ID145808, carried out using Illumina platform and MinION sequencing device (M.S., unpublished data), we identified the <italic toggle="yes">apt</italic> BGC using antiSMASH 6.0 at the default conditions.<sup><xref rid="cit53" ref-type="bibr">53</xref></sup> Then, the sequences of the <italic toggle="yes">apt</italic> genes were manually curated. BLAST analysis of individual CDSs was performed against the MIBiG 2.0 database of known gene clusters<sup><xref rid="cit35" ref-type="bibr">35</xref></sup> and against Protein Data Bank. The 16S rRNA gene sequence was analyzed following published procedures.<sup><xref rid="cit54" ref-type="bibr">54</xref></sup></p><p>The nucleotide sequences have been deposited in GenBank under accession number OM714933 (16S rRNA gene).</p></sec></sec><sec><title>Author contributions</title><p>M. I., S. D. and M. S. designed work, analyzed data and wrote the paper; A. G. performed strain cultivation, molecular networking and analyzed data; M. I. and S. I. M. identified metabolites and analyzed data; M. I. purified metabolites and elucidated structures; C. B., P. L., A. G. and A. T. performed bioassays and analyzed data. All authors contributed to critical discussions, read and approved the final manuscript.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>The authors declare the following competing financial interest(s): M. I., C. B., S. I. M., S. D. and M. S. are inventors of patent on allopeptimicins owned by NAICONS. M. I., A. G., C. B., A. T., S. I. M., S. D. and M. S. are employees and shareholders of NAICONS.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="RA-012-D2RA02094G-s001" position="float" content-type="local-data"><label>RA-012-D2RA02094G-s001</label><media xlink:href="RA-012-D2RA02094G-s001.pdf" id="d64e3601" position="anchor"/></supplementary-material></sec></body><back><ack><p>This work was supported by grants to NAICONS from Italian Ministry of Research (No. DM60066) and to KtedoGen from the European Union's Horizon 2020 research and innovation program under grant agreement no. 664588 (Nomorfilm). The authors thank Joao C. Cruz for early contributions to this project.</p></ack><ref-list><title>References</title><ref id="cit1"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miethke</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pieroni</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Br&#x000f6;nstrup</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hammann</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Halby</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Arimondo</surname><given-names>P. B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Glaser</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Aigle</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bode</surname><given-names>H. B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Moreira</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Medema</surname><given-names>M. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pernodet</surname><given-names>J. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Stadler</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Tormo</surname><given-names>J. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Genilloud</surname><given-names>O.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Truman</surname><given-names>A. W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Weissman</surname><given-names>K. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Takano</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sabatini</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Stegmann</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Br&#x000f6;tz-Oesterhelt</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wohlleben</surname><given-names>W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Seemann</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Empting</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hirsch</surname><given-names>A. K. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Loretz</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lehr</surname><given-names>C. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Titz</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Herrmann</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jaeger</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Alt</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hesterkamp</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Winterhalter</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Schiefer</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pfarr</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hoerauf</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Graz</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Graz</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lindvall</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ramurthy</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Karl&#x000e9;n</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>van Dongen</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Petkovic</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Keller</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Peyrane</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Fraisse</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Piddock</surname><given-names>L. J. V.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gilbert</surname><given-names>I. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Moser</surname><given-names>H. E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><source>Nat. Rev. Chem.</source><year>2021</year><volume>19</volume><fpage>1</fpage><lpage>24</lpage></element-citation></ref><ref id="cit2"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Newman</surname><given-names>D. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cragg</surname><given-names>G. M.</given-names></name>
</person-group><source>J. Nat. Prod.</source><year>2020</year><volume>83</volume><fpage>770</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id><?supplied-pmid 32162523?><pub-id pub-id-type="pmid">32162523</pub-id></element-citation></ref><ref id="cit3"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kealey</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Creaven</surname><given-names>C. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>C. D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Brady</surname><given-names>C. B.</given-names></name>
</person-group><source>Biotechnol. Lett.</source><year>2017</year><volume>39</volume><fpage>805</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1007/s10529-017-2311-8</pub-id><?supplied-pmid 28275884?><pub-id pub-id-type="pmid">28275884</pub-id></element-citation></ref><ref id="cit4"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Medema</surname><given-names>M. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Fischbach</surname><given-names>M. A.</given-names></name>
</person-group><source>Nat. Chem. Biol.</source><year>2015</year><volume>11</volume><fpage>639</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1884</pub-id><?supplied-pmid 26284671?><pub-id pub-id-type="pmid">26284671</pub-id></element-citation></ref><ref id="cit5"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Carver</surname><given-names>J. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Phelan</surname><given-names>V. V.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sanchez</surname><given-names>L. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Garg</surname><given-names>N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Peng</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>D. D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Watrous</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kapono</surname><given-names>C. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Luzzatto-Knaan</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Porto</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bouslimani</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Melnik</surname><given-names>A. V.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Meehan</surname><given-names>M. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>W. T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cr&#x000fc;semann</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Boudreau</surname><given-names>P. D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Esquenazi</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sandoval-Calder&#x000f3;n</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kersten</surname><given-names>R. D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pace</surname><given-names>L. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Quinn</surname><given-names>R. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Duncan</surname><given-names>K. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hsu</surname><given-names>C. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Floros</surname><given-names>D. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gavilan</surname><given-names>R. G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kleigrewe</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Northen</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Dutton</surname><given-names>R. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Parrot</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Carlson</surname><given-names>E. E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Aigle</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Michelsen</surname><given-names>C. F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jelsbak</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sohlenkamp</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pevzner</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Edlund</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>McLean</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Piel</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>B. T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gerwick</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Liaw</surname><given-names>C. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>Y. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Humpf</surname><given-names>H. U.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maansson</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Keyzers</surname><given-names>R. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sims</surname><given-names>A. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Johnson</surname><given-names>A. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sidebottom</surname><given-names>A. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sedio</surname><given-names>B. E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Klitgaard</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Larson</surname><given-names>C. B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cab</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Torres-Mendoza</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gonzalez</surname><given-names>D. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Silva</surname><given-names>D. B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Marques</surname><given-names>L. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Demarque</surname><given-names>D. P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pociute</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>O'Neill</surname><given-names>E. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Briand</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Helfrich</surname><given-names>E. J. N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Granatosky</surname><given-names>E. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Glukhov</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ryffel</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Houson</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Mohimani</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kharbush</surname><given-names>J. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zeng</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Vorholt</surname><given-names>J. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kurita</surname><given-names>K. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Charusanti</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>McPhail</surname><given-names>K. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Nielsen</surname><given-names>K. F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Vuong</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Elfeki</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Traxler</surname><given-names>M. F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Engene</surname><given-names>N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Koyama</surname><given-names>N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Vining</surname><given-names>O. B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Baric</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Silva</surname><given-names>R. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Mascuch</surname><given-names>S. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Tomasi</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jenkins</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Macherla</surname><given-names>V.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hoffman</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Agarwal</surname><given-names>V.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>P. G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Dai</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Neupane</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gurr</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Rodr&#x000ed;guez</surname><given-names>A. M. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lamsa</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Dorrestein</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Duggan</surname><given-names>B. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Almaliti</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Allard</surname><given-names>P. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Phapale</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Nothias</surname><given-names>L. F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Alexandrov</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Litaudon</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wolfender</surname><given-names>J. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kyle</surname><given-names>J. E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Metz</surname><given-names>T. O.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Peryea</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>D. T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>VanLeer</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Shinn</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jadhav</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Waters</surname><given-names>K. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>X.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Knight</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jensen</surname><given-names>P. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Palsson</surname><given-names>B. O.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pogliano</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Linington</surname><given-names>R. G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Guti&#x000e9;rrez</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lopes</surname><given-names>N. P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gerwick</surname><given-names>W. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Moore</surname><given-names>B. S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bandeira</surname><given-names>N.</given-names></name>
</person-group><source>Nat. Biotechnol.</source><year>2016</year><volume>34</volume><fpage>828</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1038/nbt.3597</pub-id><?supplied-pmid 27504778?><pub-id pub-id-type="pmid">27504778</pub-id></element-citation></ref><ref id="cit6"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Misra</surname><given-names>B. B.</given-names></name>
</person-group><source>Metabolomics</source><year>2021</year><volume>17</volume><fpage>49</fpage><pub-id pub-id-type="doi">10.1007/s11306-021-01796-1</pub-id><?supplied-pmid 33977389?><pub-id pub-id-type="pmid">33977389</pub-id></element-citation></ref><ref id="cit7"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jarmusch</surname><given-names>S. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>van der Hooft</surname><given-names>J. J. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jarmusch</surname><given-names>A. K.</given-names></name>
</person-group><source>Nat. Prod. Rep.</source><year>2021</year><volume>38</volume><fpage>2066</fpage><lpage>2082</lpage><pub-id pub-id-type="doi">10.1039/D1NP00040C</pub-id><pub-id pub-id-type="pmid">34612288</pub-id></element-citation></ref><ref id="cit8"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zdouc</surname><given-names>M. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Iorio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maffioli</surname><given-names>S. I.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cr&#x000fc;semann</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio</surname><given-names>M.</given-names></name>
</person-group><source>J. Nat. Prod.</source><year>2021</year><volume>84</volume><fpage>204</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.0c00807</pub-id><?supplied-pmid 33496580?><pub-id pub-id-type="pmid">33496580</pub-id></element-citation></ref><ref id="cit9"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zdouc</surname><given-names>M. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Alanjary</surname><given-names>M. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zaraz&#x000fa;a</surname><given-names>G. S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maffioli</surname><given-names>S. I.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cr&#x000fc;semann</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Medema</surname><given-names>M. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio</surname><given-names>M.</given-names></name>
</person-group><source>Cell Chem. Biol.</source><year>2021</year><volume>28</volume><fpage>733</fpage><lpage>739.e4</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2020.11.009</pub-id><?supplied-pmid 33321099?><pub-id pub-id-type="pmid">33321099</pub-id></element-citation></ref><ref id="cit10"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hug</surname><given-names>J. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Frank</surname><given-names>N. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Walt</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>&#x00160;enica</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Panter</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><source>Molecules</source><year>2021</year><volume>26</volume><fpage>7483</fpage><pub-id pub-id-type="doi">10.3390/molecules26247483</pub-id><?supplied-pmid 34946566?><pub-id pub-id-type="pmid">34946566</pub-id></element-citation></ref><ref id="cit11"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iorio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Tocchetti</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cruz</surname><given-names>J. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Del Gatto</surname><given-names>G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Brunati</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maffioli</surname><given-names>S. I.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><source>Antibiotics</source><year>2018</year><volume>7</volume><fpage>47</fpage><pub-id pub-id-type="doi">10.3390/antibiotics7020047</pub-id><?supplied-pmid 29904034?><pub-id pub-id-type="pmid">29904034</pub-id></element-citation></ref><ref id="cit12"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iorio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cruz</surname><given-names>J. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Simone</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bernasconi</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Brunati</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maffioli</surname><given-names>S. I.</given-names></name>
</person-group><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>819</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00654</pub-id><?supplied-pmid 28218529?><pub-id pub-id-type="pmid">28218529</pub-id></element-citation></ref><ref id="cit13"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cruz</surname><given-names>J. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maffioli</surname><given-names>S. I.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bernasconi</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Brunati</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gaspari</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wellington</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><source>J. Antibiot.</source><year>2017</year><volume>70</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/ja.2016.62</pub-id><?supplied-pmid 27220409?><pub-id pub-id-type="pmid">27220409</pub-id></element-citation></ref><ref id="cit14"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cruz</surname><given-names>J. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Iorio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Monciardini</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Simone</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Brunati</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gaspari</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maffioli</surname><given-names>S. I.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wellington</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>2642</fpage><lpage>2647</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b00576</pub-id><?supplied-pmid 26512731?><pub-id pub-id-type="pmid">26512731</pub-id></element-citation></ref><ref id="cit15"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mazzetti</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ornaghi</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gaspari</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Parapini</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maffioli</surname><given-names>S. I.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><source>J. Nat. Prod.</source><year>2012</year><volume>75</volume><fpage>1044</fpage><lpage>1050</lpage><pub-id pub-id-type="doi">10.1021/np300003n</pub-id><?supplied-pmid 22616554?><pub-id pub-id-type="pmid">22616554</pub-id></element-citation></ref><ref id="cit16"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pozzi</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Simone</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Mazzetti</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maffioli</surname><given-names>S. I.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Monciardini</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cavaletti</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bamonte</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><source>J. Antibiot.</source><year>2011</year><volume>64</volume><fpage>133</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1038/ja.2010.149</pub-id><?supplied-pmid 21119678?><pub-id pub-id-type="pmid">21119678</pub-id></element-citation></ref><ref id="cit17"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bruns</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cr&#x000fc;semann</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Letzel</surname><given-names>A. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Alanjary</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>McInerney</surname><given-names>J. O.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jensen</surname><given-names>P. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Schulz</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Moore</surname><given-names>B.
S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ziemert</surname><given-names>N.</given-names></name>
</person-group><source>ISME J.</source><year>2018</year><volume>12</volume><fpage>320</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1038/ismej.2017.137</pub-id><?supplied-pmid 28809850?><pub-id pub-id-type="pmid">28809850</pub-id></element-citation></ref><ref id="cit18"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miyanaga</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kudo</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Eguchi</surname><given-names>T.</given-names></name>
</person-group><source>Curr. Opin. Chem. Biol.</source><year>2016</year><volume>35</volume><fpage>58</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2016.08.030</pub-id><?supplied-pmid 27619002?><pub-id pub-id-type="pmid">27619002</pub-id></element-citation></ref><ref id="cit19"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kudo</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Miyanaga</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Eguchi</surname><given-names>T.</given-names></name>
</person-group><source>Nat. Prod. Rep.</source><year>2014</year><volume>31</volume><fpage>1056</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1039/C4NP00007B</pub-id><?supplied-pmid 24926851?><pub-id pub-id-type="pmid">24926851</pub-id></element-citation></ref><ref id="cit20"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takaishi</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kudo</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Eguchi</surname><given-names>T.</given-names></name>
</person-group><source>J. Antibiot.</source><year>2013</year><volume>66</volume><fpage>691</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1038/ja.2013.76</pub-id><?supplied-pmid 23921821?><pub-id pub-id-type="pmid">23921821</pub-id></element-citation></ref><ref id="cit21"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cie&#x0015b;lak</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Miyanaga</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Takaku</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Takaishi</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Amagai</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kudo</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Eguchi</surname><given-names>T.</given-names></name>
</person-group><source>Proteins</source><year>2017</year><volume>85</volume><fpage>1238</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1002/prot.25284</pub-id><?supplied-pmid 28316096?><pub-id pub-id-type="pmid">28316096</pub-id></element-citation></ref><ref id="cit22"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yin</surname><given-names>Z.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Dickshat</surname><given-names>J. S.</given-names></name>
</person-group><source>Nat. Prod. Rep.</source><year>2021</year><volume>38</volume><fpage>1445</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1039/D0NP00091D</pub-id><?supplied-pmid 33475122?><pub-id pub-id-type="pmid">33475122</pub-id></element-citation></ref><ref id="cit23"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>W.</given-names></name>
</person-group><source>Appl. Microbiol. Biotechnol.</source><year>2018</year><volume>102</volume><fpage>2225</fpage><lpage>2234</lpage><pub-id pub-id-type="doi">10.1007/s00253-017-8729-z</pub-id><?supplied-pmid 29349495?><pub-id pub-id-type="pmid">29349495</pub-id></element-citation></ref><ref id="cit24"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>S. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Guo</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>J. S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Park</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Dahse</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jung</surname><given-names>W. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Beemelmanns</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>K. H.</given-names></name>
</person-group><source>Org. Chem. Front.</source><year>2021</year><volume>8</volume><fpage>4791</fpage><lpage>4798</lpage><pub-id pub-id-type="doi">10.1039/D1QO00610J</pub-id></element-citation></ref><ref id="cit25"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Z.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Luo</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zuo</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>Y. Q.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ju</surname><given-names>J.</given-names></name>
</person-group><source>Angew. Chem., Int. Ed. Engl.</source><year>2011</year><volume>50</volume><fpage>7797</fpage><lpage>7802</lpage><pub-id pub-id-type="doi">10.1002/anie.201102305</pub-id><?supplied-pmid 21726028?><pub-id pub-id-type="pmid">21726028</pub-id></element-citation></ref><ref id="cit26"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fujimori</surname><given-names>D. G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hrvatin</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Neumann</surname><given-names>C. S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Strieker</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Marahiel</surname><given-names>M. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Walsh CT</surname><given-names>C. T.</given-names></name>
</person-group><source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2007</year><volume>104</volume><fpage>16498</fpage><lpage>16503</lpage><pub-id pub-id-type="doi">10.1073/pnas.0708242104</pub-id><?supplied-pmid 17940045?><pub-id pub-id-type="pmid">17940045</pub-id></element-citation></ref><ref id="cit27"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Walsh</surname><given-names>C. T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>O'Brien</surname><given-names>R. V.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Khosla</surname><given-names>C.</given-names></name>
</person-group><source>Angew. Chem., Int. Ed.</source><year>2013</year><volume>52</volume><fpage>7098</fpage><lpage>7124</lpage><pub-id pub-id-type="doi">10.1002/anie.201208344</pub-id><?supplied-pmid 23729217?><pub-id pub-id-type="pmid">23729217</pub-id></element-citation></ref><ref id="cit28"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Q.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Qin</surname><given-names>X.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gui</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Li</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ju</surname><given-names>J.</given-names></name>
</person-group><source>J. Am. Chem. Soc.</source><year>2016</year><volume>138</volume><fpage>408</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1021/jacs.5b11380</pub-id><?supplied-pmid 26669414?><pub-id pub-id-type="pmid">26669414</pub-id></element-citation></ref><ref id="cit29"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>K. D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Andersen</surname><given-names>R. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ryan</surname><given-names>K. S.</given-names></name>
</person-group><source>Nat. Prod. Rep.</source><year>2019</year><volume>36</volume><fpage>1628</fpage><lpage>1653</lpage><pub-id pub-id-type="doi">10.1039/C8NP00076J</pub-id><?supplied-pmid 30949650?><pub-id pub-id-type="pmid">30949650</pub-id></element-citation></ref><ref id="cit30"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wan</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Qi</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gong</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Deng</surname><given-names>Z.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>W.</given-names></name>
</person-group><source>Microb. Cell Fact.</source><year>2016</year><volume>15</volume><fpage>160</fpage><pub-id pub-id-type="doi">10.1186/s12934-016-0559-7</pub-id><?supplied-pmid 27655321?><pub-id pub-id-type="pmid">27655321</pub-id></element-citation></ref><ref id="cit31"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lloyd</surname><given-names>E. P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Moshos</surname><given-names>K. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Townsend</surname><given-names>C. A.</given-names></name>
</person-group><source>ChemBioChem</source><year>2014</year><volume>15</volume><fpage>320</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1002/cbic.201300319</pub-id><?supplied-pmid 24420617?><pub-id pub-id-type="pmid">24420617</pub-id></element-citation></ref><ref id="cit32"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kato</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Suzuki</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ida</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maebashi</surname><given-names>K.</given-names></name>
</person-group><source>J. Antimicrob. Chemother.</source><year>2010</year><volume>65</volume><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1093/jac/dkp394</pub-id><?supplied-pmid 19889788?><pub-id pub-id-type="pmid">19889788</pub-id></element-citation></ref><ref id="cit33"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>B. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Drake</surname><given-names>E. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Aldrich</surname><given-names>C. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gulick</surname><given-names>A. M.</given-names></name>
</person-group><source>J. Biol. Chem.</source><year>2016</year><volume>43</volume><fpage>22559</fpage><lpage>22571</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.746297</pub-id><?supplied-pmid 27597544?><pub-id pub-id-type="pmid">27597544</pub-id></element-citation></ref><ref id="cit34"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Curran</surname><given-names>S. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pereira</surname><given-names>J. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Baluyot</surname><given-names>M. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lake</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Puetz</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Rosenburg</surname><given-names>D. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Adams</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Keasling</surname><given-names>J. D.</given-names></name>
</person-group><source>Biochemistry</source><year>2020</year><volume>59</volume><fpage>1630</fpage><lpage>1639</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.0c00126</pub-id><?supplied-pmid 32250597?><pub-id pub-id-type="pmid">32250597</pub-id></element-citation></ref><ref id="cit35"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kautsar</surname><given-names>S. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Blin</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Shaw</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>J. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Terlouw</surname><given-names>B. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>van der Hooft</surname><given-names>J. J. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>van Santen</surname><given-names>J. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Tracanna</surname><given-names>V.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Suarez Duran</surname><given-names>H. G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pascal Andreu</surname><given-names>V.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Selem-Mojica</surname><given-names>N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Alanjary</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Robinson</surname><given-names>S. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lund</surname><given-names>G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Epstein</surname><given-names>S. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sisto</surname><given-names>A. C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Charkoudian</surname><given-names>L. K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Collemare</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Linington</surname><given-names>R. G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Medema MH</surname><given-names>M. H.</given-names></name>
</person-group><source>Nucleic Acids Res.</source><year>2020</year><volume>48</volume><fpage>D454</fpage><lpage>D458</lpage><pub-id pub-id-type="pmid">31612915</pub-id></element-citation></ref><ref id="cit36"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tocchetti</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Iorio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hamid</surname><given-names>Z.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Armirotti</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Reggiani</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><source>Molecules</source><year>2021</year><volume>26</volume><fpage>6764</fpage><pub-id pub-id-type="doi">10.3390/molecules26226764</pub-id><?supplied-pmid 34833857?><pub-id pub-id-type="pmid">34833857</pub-id></element-citation></ref><ref id="cit37"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jokela</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Oftedal</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Herfindal</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Permi</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wahlsten</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>D&#x000f8;skeland</surname><given-names>S. O.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sivonen</surname><given-names>K.</given-names></name>
</person-group><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e41222</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0041222</pub-id><?supplied-pmid 22829929?><pub-id pub-id-type="pmid">22829929</pub-id></element-citation></ref><ref id="cit38"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pet&#x00159;&#x000ed;&#x0010d;kov&#x000e1;</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Posp&#x000ed;&#x00161;il</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kuzma</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Tylov&#x000e1;</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>J&#x000e1;gr</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Tomek</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Chro&#x00148;&#x000e1;kov&#x000e1;</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Brabcov&#x000e1;</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>And&#x0011b;ra</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kri&#x00161;t&#x0016f;fek</surname><given-names>V.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Pet&#x00159;&#x000ed;&#x0010d;ek</surname><given-names>M.</given-names></name>
</person-group><source>Chembiochem</source><year>2014</year><volume>15</volume><fpage>1334</fpage><lpage>1345</lpage><pub-id pub-id-type="doi">10.1002/cbic.201400068</pub-id><?supplied-pmid 24838618?><pub-id pub-id-type="pmid">24838618</pub-id></element-citation></ref><ref id="cit39"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kunze</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Reichenbach</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>H&#x000f6;fle</surname><given-names>G.</given-names></name>
</person-group><source>J. Antibiot.</source><year>2005</year><volume>58</volume><fpage>244</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1038/ja.2005.28</pub-id><?supplied-pmid 15981410?><pub-id pub-id-type="pmid">15981410</pub-id></element-citation></ref><ref id="cit40"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niggemann</surname><given-names>J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bedorf</surname><given-names>N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Fl&#x000f6;rke</surname><given-names>U.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Steinmetz</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Gerth</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Reichenbach</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>H&#x000f6;fle</surname><given-names>G.</given-names></name>
</person-group><source>EurJOC</source><year>2005</year><volume>23</volume><fpage>5013</fpage><lpage>5018</lpage></element-citation></ref><ref id="cit41"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Exposito</surname><given-names>M. A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Lopez</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Fernandez</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Vazquez</surname><given-names>M. J.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Debitus</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Iglesias</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Jimenez</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Quinoa</surname><given-names>E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Riguera</surname><given-names>R.</given-names></name>
</person-group><source>Tetrahedron</source><year>1998</year><volume>54</volume><fpage>7539</fpage><lpage>7550</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(98)00388-3</pub-id></element-citation></ref><ref id="cit42"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schmidt</surname><given-names>E. W.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Raventos-Suarez</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bifano</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Menendez</surname><given-names>A. T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Fairchild</surname><given-names>C. R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Faulkner</surname><given-names>D. J.</given-names></name>
</person-group><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>475</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1021/np034035z</pub-id><?supplied-pmid 15043437?><pub-id pub-id-type="pmid">15043437</pub-id></element-citation></ref><ref id="cit43"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okamoto</surname><given-names>Y.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ojika</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kato</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sakagami</surname><given-names>Y.</given-names></name>
</person-group><source>Tetrahedron</source><year>2000</year><volume>56</volume><fpage>5813</fpage><lpage>5818</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(00)00544-5</pub-id></element-citation></ref><ref id="cit44"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seger</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sturm</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Stuppner</surname><given-names>H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Butt</surname><given-names>T. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Strasser</surname><given-names>H.</given-names></name>
</person-group><source>J. Chromatogr. A</source><year>2004</year><volume>1061</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2004.10.063</pub-id><?supplied-pmid 15633742?><pub-id pub-id-type="pmid">15633742</pub-id></element-citation></ref><ref id="cit45"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Medema</surname><given-names>M. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>de Rond</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Moore</surname><given-names>B. S.</given-names></name>
</person-group><source>Nat. Rev. Genet.</source><year>2021</year><volume>22</volume><fpage>553</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1038/s41576-021-00363-7</pub-id><?supplied-pmid 34083778?><pub-id pub-id-type="pmid">34083778</pub-id></element-citation></ref><ref id="cit46"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lukowski</surname><given-names>A. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Denomme</surname><given-names>N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hinze</surname><given-names>M. E.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Hall</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Isom</surname><given-names>L. L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Narayan</surname><given-names>A.</given-names></name>
</person-group><source>ACS Chem. Biol.</source><year>2019</year><volume>14</volume><fpage>941</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1021/acschembio.9b00123</pub-id><?supplied-pmid 30983320?><pub-id pub-id-type="pmid">30983320</pub-id></element-citation></ref><ref id="cit47"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Monciardini</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio M</surname><given-names>M.</given-names></name>
</person-group><source>Methods Enzymol.</source><year>2009</year><volume>458</volume><fpage>3</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">19374977</pub-id></element-citation></ref><ref id="cit48"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pluskal</surname><given-names>T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Castillo</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Villar-Briones</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Oresic</surname><given-names>M.</given-names></name>
</person-group><source>BMC Bioinf.</source><year>2010</year><volume>23</volume><issue>11</issue><fpage>395</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-11-395</pub-id></element-citation></ref><ref id="cit49"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shannon</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Markiel</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ozier</surname><given-names>O.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Baliga</surname><given-names>N. S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J. T.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ramage</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Amin</surname><given-names>N.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Schwikowski</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Ideker</surname><given-names>T.</given-names></name>
</person-group><source>Genome Res.</source><year>2003</year><volume>13</volume><fpage>2498</fpage><lpage>2504</lpage><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><?supplied-pmid 14597658?><pub-id pub-id-type="pmid">14597658</pub-id></element-citation></ref><ref id="cit50"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Piccolomini</surname><given-names>R.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Di Bonaventura</surname><given-names>G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Catamo</surname><given-names>G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Carbone</surname><given-names>F.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Neri</surname><given-names>M.</given-names></name>
</person-group><source>J. Clin. Microbiol.</source><year>1997</year><volume>35</volume><fpage>1842</fpage><lpage>1846</lpage><pub-id pub-id-type="doi">10.1128/jcm.35.7.1842-1846.1997</pub-id><?supplied-pmid 9196205?><pub-id pub-id-type="pmid">9196205</pub-id></element-citation></ref><ref id="cit51"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maffioli</surname><given-names>S. I.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Monciardini</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Catacchio</surname><given-names>B.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Mazzetti</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>M&#x000fc;nch</surname><given-names>D.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Brunati</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sahl</surname><given-names>H. G.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio S</surname><given-names>S.</given-names></name>
</person-group><source>ACS Chem. Biol.</source><year>2015</year><volume>10</volume><fpage>1034</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1021/cb500878h</pub-id><?supplied-pmid 25574687?><pub-id pub-id-type="pmid">25574687</pub-id></element-citation></ref><ref id="cit52"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Monciardini</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Bernasconi</surname><given-names>A.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Iorio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Brunati</surname><given-names>C.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Campochiaro</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Landini</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Maffioli</surname><given-names>S. I.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><source>J. Nat. Prod.</source><year>2019</year><volume>82</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.8b00354</pub-id><?supplied-pmid 30615447?><pub-id pub-id-type="pmid">30615447</pub-id></element-citation></ref><ref id="cit53"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blin</surname><given-names>K.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Shaw</surname><given-names>S.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Kloosterman</surname><given-names>A. M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>van Wezel</surname><given-names>G. P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Medema</surname><given-names>M. H.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>W29</fpage><lpage>W35</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab335</pub-id><?supplied-pmid 33978755?><pub-id pub-id-type="pmid">33978755</pub-id></element-citation></ref><ref id="cit54"><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mazza</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Monciardini</surname><given-names>P.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Cavaletti</surname><given-names>L.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Sosio</surname><given-names>M.</given-names></name>
</person-group><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><source>Microb. Ecol.</source><year>2003</year><volume>45</volume><fpage>362</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1007/s00248-002-2038-4</pub-id><?supplied-pmid 12704554?><pub-id pub-id-type="pmid">12704554</pub-id></element-citation></ref></ref-list></back></article>